[
    {
        "title": "Document and Entity Information", 
        "Document and Entity Information [Abstract]": {
            "Entity Registrant Name": {
                "value": "AGILENT TECHNOLOGIES INC.", 
                "time": "6 months ended"
            }, 
            "Entity Central Index Key": {
                "value": 1090872, 
                "time": "6 months ended"
            }, 
            "Current Fiscal Year End Date": {
                "value": "--10-31", 
                "time": "6 months ended"
            }, 
            "Entity Well-known Seasoned Issuer": {
                "value": "Yes", 
                "time": "6 months ended"
            }, 
            "Entity Voluntary Filers": {
                "value": "No", 
                "time": "6 months ended"
            }, 
            "Entity Current Reporting Status": {
                "value": "Yes", 
                "time": "6 months ended"
            }, 
            "Entity Filer Category": {
                "value": "Large Accelerated Filer", 
                "time": "6 months ended"
            }, 
            "Entity Common Stock, Shares Outstanding": {
                "value": 325521700, 
                "time": "6 months ended"
            }, 
            "Document Fiscal Year Focus": {
                "value": 2016, 
                "time": "6 months ended"
            }, 
            "Document Fiscal Period Focus": {
                "value": "Q2", 
                "time": "6 months ended"
            }, 
            "Document Type": {
                "value": "10-Q", 
                "time": "6 months ended"
            }, 
            "Amendment Flag": {
                "value": "false", 
                "time": "6 months ended"
            }, 
            "Document Period End Date": {
                "value": "Apr. 30,\n\t\t2016", 
                "time": "6 months ended"
            }
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($) shares in Millions, $ in Millions", 
        "Net revenue:": {
            "Products": [
                {
                    "value": 787, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 750, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1582, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1559, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Services and other": [
                {
                    "value": 232, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 213, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 465, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 430, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Total net revenue": [
                {
                    "value": 1019, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 963, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2047, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1989, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Costs and expenses:": {
            "Cost of products": [
                {
                    "value": 357, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 359, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 722, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 749, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Cost of services and other": [
                {
                    "value": 132, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 124, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 258, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 247, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Total costs": [
                {
                    "value": 489, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 483, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 980, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 996, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Research and development": [
                {
                    "value": 81, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 81, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 159, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 169, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Selling, general and administrative": [
                {
                    "value": 318, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 292, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 622, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 602, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Total costs and expenses": [
                {
                    "value": 888, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 856, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1761, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1767, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income from operations": [
                {
                    "value": 131, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 107, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 286, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 222, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest income": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest expense": [
                {
                    "value": -18, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -17, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -36, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -33, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other income (expense), net": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 4, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 16, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income from continuing operations before taxes": [
                {
                    "value": 117, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 96, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 259, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 209, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Provision for income taxes": [
                {
                    "value": 26, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 45, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 24, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income from continuing operations": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 92, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 185, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loss from discontinued operations, net of tax benefit of $0, $0, $0 and $(2)": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net income": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 87, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Net income per share - basic": {
            "Income from continuing operations": [
                {
                    "value": 0.28, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.28, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0.65, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.55, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loss from discontinued operations": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -0.02, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -0.1, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net income per share - basic": [
                {
                    "value": 0.28, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.26, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0.65, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.45, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Net income per share - diluted": {
            "Income from continuing operations": [
                {
                    "value": 0.28, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.27, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0.65, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.55, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loss from discontinued operations": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -0.01, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -0.1, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net income per share - diluted": [
                {
                    "value": 0.28, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.26, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0.65, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.45, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Weighted average shares used in computing net income per share:": {
            "Basic (in shares)": [
                {
                    "value": 326, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 334, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 327, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 335, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Diluted (in shares)": [
                {
                    "value": 328, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 337, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 330, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 337, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Cash dividends declared per common share": [
                {
                    "value": 0.115, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0.23, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (PARENTHETICAL) - USD ($) $ in Millions", 
        "CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (PARENTHETICAL) - USD ($) $ in Millions": {
            "Income tax benefit from discontinued operations": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Millions", 
        "Statement of Comprehensive Income [Abstract]": {
            "Net income": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 87, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Other comprehensive income (loss):": {
            "Unrealized gain on derivative instruments, net of tax expense (benefit) of $(4), $(1), $(3) and $2": [
                {
                    "value": -9, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Amounts reclassified into earnings related to derivative instruments, net of tax benefit of $(1), $(2), $(1) and $(3)": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Foreign currency translation, net of tax expense (benefit) of $8, $(1), $7 and $(7)": [
                {
                    "value": 145, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 89, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -271, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Net defined benefit pension cost and post retirement plan costs:": {
            "Change in actuarial net loss, net of tax expense of $3, $2, $7 and $4": [
                {
                    "value": 6, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 21, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 10, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Change in net prior service benefit, net of tax benefit of $(1), $(1), $(6) and $(3)": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -11, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other comprehensive loss": [
                {
                    "value": 139, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 92, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -268, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Total comprehensive income (loss)": [
                {
                    "value": 230, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 78, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 306, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -118, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($) $ in Millions", 
        "Other comprehensive income (loss), tax, parenthetical disclosures": {
            "Unrealized gain (loss) on derivative instruments, tax": [
                {
                    "value": -4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Amounts reclassified into earnings related to derivative instruments, tax": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Foreign currency translation, tax": [
                {
                    "value": 8, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -7, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Net defined benefit pension cost and post retirement plan costs, tax": {
            "Change in actuarial net loss, tax": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Change in net prior service benefit, tax": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($) $ in Millions", 
        "Current assets:": {
            "Cash and cash equivalents": [
                {
                    "value": 2139, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2003, 
                    "date": "oct 31 2015"
                }
            ], 
            "Short-term restricted cash and cash equivalents": {
                "value": 242, 
                "date": "oct 31 2015"
            }, 
            "Accounts receivable, net": [
                {
                    "value": 602, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 606, 
                    "date": "oct 31 2015"
                }
            ], 
            "Inventory": [
                {
                    "value": 555, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 541, 
                    "date": "oct 31 2015"
                }
            ], 
            "Other current assets": [
                {
                    "value": 192, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 294, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total current assets": [
                {
                    "value": 3488, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3686, 
                    "date": "oct 31 2015"
                }
            ], 
            "Property, plant and equipment, net": [
                {
                    "value": 610, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 604, 
                    "date": "oct 31 2015"
                }
            ], 
            "Goodwill": [
                {
                    "value": 2556, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2366, 
                    "date": "oct 31 2015"
                }
            ], 
            "Other intangible assets, net": [
                {
                    "value": 490, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 445, 
                    "date": "oct 31 2015"
                }
            ], 
            "Long-term investments": [
                {
                    "value": 157, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 86, 
                    "date": "oct 31 2015"
                }
            ], 
            "Other assets": [
                {
                    "value": 339, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 292, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total assets": [
                {
                    "value": 7640, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7479, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Current liabilities:": {
            "Accounts payable": [
                {
                    "value": 220, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 279, 
                    "date": "oct 31 2015"
                }
            ], 
            "Employee compensation and benefits": [
                {
                    "value": 211, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 221, 
                    "date": "oct 31 2015"
                }
            ], 
            "Deferred revenue": [
                {
                    "value": 279, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 258, 
                    "date": "oct 31 2015"
                }
            ], 
            "Short-term debt": [
                {
                    "value": 235, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Other accrued liabilities": [
                {
                    "value": 188, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 218, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total current liabilities": [
                {
                    "value": 1133, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 976, 
                    "date": "oct 31 2015"
                }
            ], 
            "Long-term debt": [
                {
                    "value": 1654, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1655, 
                    "date": "oct 31 2015"
                }
            ], 
            "Retirement and post-retirement benefits": [
                {
                    "value": 242, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 264, 
                    "date": "oct 31 2015"
                }
            ], 
            "Other long-term liabilities": [
                {
                    "value": 446, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 414, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total liabilities": [
                {
                    "value": 3475, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3309, 
                    "date": "oct 31 2015"
                }
            ], 
            "Commitments and Contingencies (Note 12)": [
                {
                    "value": " ", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": " ", 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Stockholders' equity:": {
            "Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Common stock; $0.01 par value; 2 billion shares authorized; 612 million shares at April 30, 2016 and 611 million shares at October 31, 2015, issued": [
                {
                    "value": 6, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "oct 31 2015"
                }
            ], 
            "Treasury stock at cost; 287 million shares at April 30, 2016 and 279 million shares at October 31, 2015": [
                {
                    "value": -10368, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -10074, 
                    "date": "oct 31 2015"
                }
            ], 
            "Additional paid-in-capital": [
                {
                    "value": 9103, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 9045, 
                    "date": "oct 31 2015"
                }
            ], 
            "Retained earnings": [
                {
                    "value": 5720, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 5581, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated other comprehensive loss": [
                {
                    "value": -299, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -391, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total stockholder's equity": [
                {
                    "value": 4162, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4167, 
                    "date": "oct 31 2015"
                }
            ], 
            "Non-controlling interest": [
                {
                    "value": 3, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total equity": [
                {
                    "value": 4165, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4170, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total liabilities and equity": [
                {
                    "value": 7640, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7479, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical) - $ / shares", 
        "Stockholders' equity:": {
            "Preferred stock, par value (in dollars per share)": [
                {
                    "value": 0.01, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.01, 
                    "date": "oct 31 2015"
                }
            ], 
            "Preferred stock, shares authorized (in shares)": [
                {
                    "value": 125000000, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 125000000, 
                    "date": "oct 31 2015"
                }
            ], 
            "Preferred stock, issued and outstanding (in shares)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Common stock, par value (in dollars per share)": [
                {
                    "value": 0.01, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.01, 
                    "date": "oct 31 2015"
                }
            ], 
            "Common stock, shares authorized (in shares)": [
                {
                    "value": 2000000000, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2000000000, 
                    "date": "oct 31 2015"
                }
            ], 
            "Common stock, issued and outstanding (in shares)": [
                {
                    "value": 612000000, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 611000000, 
                    "date": "oct 31 2015"
                }
            ], 
            "Treasury stock at cost, shares (in shares)": [
                {
                    "value": 287000000, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 279000000, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", 
        "Cash flows from operating activities:": {
            "Net income": [
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Adjustments to reconcile net income to net cash provided by (used in) operating activities:": {
            "Depreciation and amortization": [
                {
                    "value": 130, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 131, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Share-based compensation": [
                {
                    "value": 36, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 33, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Deferred taxes": [
                {
                    "value": 35, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Excess and obsolete inventory related charges": [
                {
                    "value": 12, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 13, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other non-cash expense, net": [
                {
                    "value": 8, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 5, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Changes in assets and liabilities:": {
            "Accounts receivable": [
                {
                    "value": 19, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 16, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Inventory": [
                {
                    "value": -13, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -18, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Accounts payable": [
                {
                    "value": -53, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Employee compensation and benefits": [
                {
                    "value": -13, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -7, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other assets and liabilities": [
                {
                    "value": -15, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -129, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net cash provided by operating activities": [
                {
                    "value": 360, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 163, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Cash flows from investing activities:": {
            "Investments in property, plant and equipment": [
                {
                    "value": -63, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -52, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Proceeds from sale of property, plant and equipment": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loan to equity method investment": [
                {
                    "value": 3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Payment to acquire cost method investment": [
                {
                    "value": -80, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Payments to acquire equity method investments": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Payment in exchange for convertible note": [
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Change in restricted cash and cash equivalents, net": [
                {
                    "value": 245, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Proceeds from sale of investment securities": [
                {
                    "value": 1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Proceeds from divestitures": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Acquisitions of businesses and intangible assets, net of cash acquired": [
                {
                    "value": -235, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net cash used in investing activities": [
                {
                    "value": -136, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -38, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Cash flows from financing activities:": {
            "Issuance of common stock under employee stock plans": [
                {
                    "value": 32, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 40, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Payment of dividends": [
                {
                    "value": -75, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -67, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net transfer of cash and cash equivalents to Keysight": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -734, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Proceeds from revolving credit facility": [
                {
                    "value": 255, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Repayment of revolving credit facility": [
                {
                    "value": -20, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Treasury stock repurchases": [
                {
                    "value": -294, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -168, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net cash used in financing activities": [
                {
                    "value": -102, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -929, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Effect of exchange rate movements": [
                {
                    "value": 14, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -27, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net increase (decrease) in cash and cash equivalents": [
                {
                    "value": 136, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -831, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Change in cash and cash equivalents related to discontinued operations": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 810, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Cash and cash equivalents at beginning of period": [
                {
                    "value": 2003, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2218, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Cash and cash equivalents at end of period": [
                {
                    "value": 2139, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2197, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)", 
        "Accounting Policies [Abstract]": {
            "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES": {
                "value": "1. OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Overview. Agilent Technologies, Inc. (\"we\", \"Agilent\" or the \"company\"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Our fiscal year-end is October 31, and our fiscal quarters end on January 31, April 30 and July 31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters. Basis of Presentation . We have prepared the accompanying financial data for the three and six months ended April 30, 2016 and 2015 pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (GAAP) in the U.S. have been condensed or omitted pursuant to such rules and regulations. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 . In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of April 30, 2016 and October 31, 2015 , condensed consolidated statement of comprehensive income (loss) for the three and six months ended April 30, 2016 and 2015 , condensed consolidated statement of operations for the three and six months ended April 30, 2016 and 2015 , and condensed consolidated statement of cash flows for the six months ended April 30, 2016 and 2015 . Revision of Services and Other and Product Net Revenues and related Cost of Sales. In 2015, we revised amounts shown in our condensed consolidated statement of operations to more accurately reflect the character of items delivered to customers. Our diagnostic and genomics segment identified a stream of service revenues that had been presented as product revenue in the prior year. We have now revised prior year's presentation to show the revenue within services and other. The cost of sales associated with these newly identified service revenues has also been revised to align with the new presentation. For the three and six months ended April 30, 2015 services and other revenue increased $9 million and $15 million and services and other cost of sales increased $6 million and $11 million with corresponding reductions in product revenue and cost of sales. These corrections to the classifications are not considered to be material to current or prior periods and had no impact to our results of operations previously reported in our condensed consolidated statement of operations. Use of Estimates. The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on managements best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, share-based compensation, retirement and post-retirement plan assumptions and accounting for income taxes. Variable Interest Entities. We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (VIE). The company evaluates its investments in privately held companies on an ongoing basis. We have determined that as of April 30, 2016 there were no VIEs required to be consolidated in the companys consolidated financial statements because we do not have a controlling financial interest in any of the VIEs that we have invested in. We account for these investments under either the equity or cost method, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure. As of April 30, 2016, the carrying value of our investments in VIEs was $103 million with a maximum exposure of $109 million which includes our loans to our investments. The investments are included on the long term investments line of the condensed consolidated balance sheet. During the three months ended April 30, 2016, Agilent made a preferred stock investment in Lasergen for $80 million . Agilents initial ownership stake was 48 percent and we have also joined the board of Lasergen and signed a collaboration agreement. We have the option to acquire all of the remaining shares of Lasergen until March 2, 2018, for an additional consideration of $105 million . Lasergen is a VIE, however, we do not consolidate the entity in our financial statements because we do not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance. Because Agilent owns preferred stock of Lasergen, we account for this investment under the cost method. As of April 30, 2016, both the carrying value and maximum exposure of the Lasergen investment was $80 million . The maximum exposure is equal to the carrying value because we do not have future funding commitments. Fair Value of Financial Instruments. The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments is determined using quoted market prices for those securities when available. For those long-term equity investments accounted for under the cost or equity method, their carrying value approximates their estimated fair value. Equity method investments are reported at the amount of the companys initial investment and adjusted each period for the companys share of the investees income or loss and dividend paid. The fair value of our long-term debt, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy, exceeds the carrying value by approximately $87 million and $30 million as of April 30, 2016 and October 31, 2015 , respectively. The change in the excess of fair value over carrying value in the six months ended April 30, 2016 is due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 9, \"Fair Value Measurements\" for additional information on the fair value of financial instruments. Goodwill and Purchased Intangible Assets. Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required. The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers. If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units. In fiscal year 2015, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a quantitative test for goodwill impairment of the three reporting units, as of September 30, 2015. Based on the results of our testing, the fair value of these reporting units are greater than their respective carrying values. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the three and six months ended April 30, 2016 and 2015 . Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years . In-process research and development (\"IPR&D\") is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's condensed consolidated statement of operations in the period it is abandoned. Agilent's indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2015. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets is indicated. There were no indicators of impairment of indefinite-lived intangible assets during the three and six months ended April 30, 2016 and 2015 .", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Notes)", 
        "Income Tax Disclosure [Abstract]": {
            "Accounting Changes and Error Corrections [Text Block]": {
                "value": " 2. REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS During the years ended October 31, 2014 and 2015, the company identified and recorded various out of period income tax adjustments. We determined that the errors were not material to the previously issued financial statements and disclosures included in our Annual Report on Form 10-K for the year ended October 31, 2014 or for any quarterly periods included therein or through our Quarterly Report on Form 10-Q for the nine months ended July 31, 2015. However, as a result of the company presenting continuing operations and discontinued operations for the first time in our Annual Report on Form 10-K for the year ended October 31, 2015, we determined that the effect of the errors is significant to our financial results for the year ending October 31, 2014 and 2013. Accordingly, we revised our historical financial statements presented in our Form 10-K for the year ended October 31, 2015. For the three and six months ended April 30, 2016, we are presenting comparative fiscal 2015 quarterly information. The fiscal 2015 results for the three and six months ended April 30, 2015 have been revised to reflect the quarterly impact of the out of period adjustments described above. For the three months ended April 30, 2015 the following out of period adjustments were included in the as-reported column in the revision adjustment table and have been removed in the adjustments column: $4 million of tax expense related to the increase of foreign deferred tax liabilities for a prior year. In addition to the aforementioned, for the six months ended April 30, 2015, the following out of period adjustments were included in the as-reported column in the revision adjustment table and have been removed in the adjustments column: $13 million of tax benefit from the reduction in deferred tax liabilities due to tax rate changes in Denmark occurring in a prior year and $4 million of tax expense attributable to an error discovered on a prior year U.S. tax return. Three Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions, except per share data) Income from continuing operations before taxes $ 96 $ 96 Provision for income taxes 8 (4 ) 4 Income from continuing operations 88 92 Loss from discontinued operations, net of tax benefit of $0 million (5 ) (5 ) Net Income $ 83 $ 4 $ 87 Net income per share - basic Income from continuing operations $ 0.26 $ 0.28 Loss from discontinued operations (0.01 ) (0.02 ) Net income per share - basic $ 0.25 $ 0.26 Net income per share - diluted Income from continuing operations $ 0.26 $ 0.27 Loss from discontinued operations (0.01 ) (0.01 ) Net income per share - diluted $ 0.25 $ 0.26 Total comprehensive income $ 74 $ 4 $ 78 Six Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions, except per share data) Income from continuing operations before taxes $ 209 $ 209 Provision for income taxes 19 5 24 Income from continuing operations 190 185 Loss from discontinued operations, net of tax benefit of $2 (35 ) (35 ) Net Income $ 155 $ (5 ) $ 150 Net income per share - basic Income from continuing operations $ 0.57 $ 0.55 Loss from discontinued operations (0.11 ) (0.10 ) Net income per share - basic $ 0.46 $ 0.45 Net income per share - diluted Income from continuing operations $ 0.56 $ 0.55 Loss from discontinued operations (0.10 ) (0.10 ) Net income per share - diluted $ 0.46 $ 0.45 Total comprehensive loss $ (113 ) $ (5 ) $ (118 ) The adjustments resulted in the following revisions to our condensed consolidated statement of cash flow. Six Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions) Net income $ 155 $ (5 ) $ 150 Deferred taxes $ (3 ) $ 7 $ 4 Changes in assets and liabilities: Other assets and liabilities $ (127 ) $ (2 ) $ (129 ) Net cash provided by operating activities $ 163 $  $ 163", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "NEW ACCOUNTING PRONOUNCEMENTS (Notes)", 
        "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]": {
            "NEW ACCOUNTING PRONOUNCEMENTS": {
                "value": " 3. NEW ACCOUNTING PRONOUNCEMENTS There were no changes to the new accounting pronouncements as described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 except for the following: In March 2016, the Financial Accounting Standards Board (FASB) issued amendments which aim to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification of certain items on the statement of cash flows and accounting for forfeitures. The amendments are effective for us beginning November 1, 2017 with early adoption permitted. We are evaluating the timing and the impact of adopting this guidance on our consolidated financial statements and disclosures. In March 2016, the FASB issued updates related to Revenue from Contracts with Customers: Principal versus Agent Considerations. The amendments are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. The effective date for us is fiscal 2019 with early adoption permitted for us beginning November 1, 2017. The company is currently assessing the potential impact of these amendments on our consolidated financial statements. In March 2016, the FASB issued amendments for simplifying the transition to the equity method of accounting. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investors previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. The amendments are effective for us beginning November 1, 2017 and interim periods in the following year. We are evaluating the potential impact of this amendment on our consolidated financial statements. In February 2016, the FASB issued guidance which amends the existing accounting standards for leases. Consistent with existing guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification. Under the new guidance, a lessee will be required to recognize right-of-use assets and lease liabilities on the balance sheet. The new guidance is effective for us beginning November 1, 2020, and interim periods in the following year. Early adoption of this guidance is permitted and we will be required to adopt using a modified retrospective approach. We are evaluating the timing and the impact of adopting this guidance on our consolidated financial statements and disclosures. In January 2016, the FASB issued amendments to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The standard requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. The provisions under this amendment are effective for us beginning November 1, 2018, and for interim periods in the following year and early adoption is not permitted. We are evaluating the impact of adopting this guidance to our consolidated financial statements. In November 2015, the FASB issued guidance intended to simplify accounting for deferred taxes. Beginning on November 1, 2017 and including the interim periods following that date, we will be required to present all deferred tax balances as non-current. Existing GAAP guidance requires us to record deferred tax balances as either current or non-current in accordance with the classification of the underlying attributes. Early adoption of this guidance is permitted and may be applied either prospectively or retrospectively to all periods presented. We adopted this guidance at the end of the period ended April 30, 2016 prospectively and therefore, the April 30, 2016 condensed consolidated balance sheet reflects the new disclosure requirements but prior periods have not been adjusted. Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our consolidated financial statements upon adoption.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "SHARE-BASED COMPENSATION (Notes)", 
        "Share-based Compensation [Abstract]": {
            "SHARE-BASED COMPENSATION": {
                "value": " 4. SHARE-BASED COMPENSATION Agilent accounts for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our employee stock purchase plan (ESPP) and performance share awards granted to selected members of our senior management under the long-term performance plan (LTPP) based on estimated fair values. Participants in the LTPP are entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets are met. Certain LTPP awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the Total Stockholders Return (TSR) set at the beginning of the performance period. Effective November 1, 2015, the Compensation Committee of the Board of Directors approved another type of performance stock award, for the company's executive officers and other key employees. Participants in this program are also entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets based on Operating Margin (OM) over the three- year period are met. All LTPP awards granted after November 1, 2015, are subject to a one year post-vest holding period. Based on the performance metrics the final LTPP award may vary from zero to 200 percent of the target award. The maximum award value cannot exceed 300 percent of the grant date target value. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. The impact on our results for share-based compensation was as follows: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Cost of products and services $ 3 $ 2 $ 9 $ 7 Research and development 1 1 3 3 Selling, general and administrative 10 9 25 24 Total share-based compensation expense $ 14 $ 12 $ 37 $ 34 At April 30, 2016 and October 31, 2015 , there was no share-based compensation capitalized within inventory. For the six months ended April 30, 2016 and 2015, the windfall tax benefit realized from exercised stock options and similar awards was zero for both periods. The following assumptions were used to estimate the fair value of the options and LTPP grants. Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 Stock Option Plans: Weighted average risk-free interest rate  1.5%  1.7 % Dividend yield  1%  1 % Weighted average volatility  29%  28 % Expected life  5.5yrs  5.5yrs LTPP: Volatility of Agilent shares 24% 25% 24 % 25 % Volatility of selected peer-company shares 14%-50% 12%-57% 14%-50% 12%-57% Price-wise correlation with selected peers 35% 37% 35 % 37 % The fair value of share-based awards for employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. Both the Black-Scholes and Monte Carlo simulation fair value models require the use of highly subjective and complex assumptions, including the options expected life and the price volatility of the underlying stock. Due to the separation of Keysight on November 1, 2014, expected volatility for grants of options in fiscal 2015 was based on a 5.5 year average historical stock price volatility of a group of our peer companies. For the volatility of our 2016 and 2015 LTPP (TSR) grants, we used the 3 year average historical stock price volatility of a group of our peer companies. We believe our historical volatility prior to the separation of Keysight is no longer relevant to use. For the grants of options and LTPP (TSR) prior to November 1, 2014, the expected stock price volatility assumption was determined using the historical volatility of Agilents stock over the most recent historical period equivalent to the expected life of the stock options and LTPP (TSR). In developing our estimated life assumption of our employees' stock options of 5.5 years, we considered the separation of Keysight and the historical option exercise behavior for our executive employees who were granted the majority of the options in the annual grants made which we believe is representative of future behavior. No stock options were granted during the three and six months ended April 30, 2016 . The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the purchase price and uses the purchase date to establish the fair market value. The estimated fair value of restricted stock unit and LTPP (OM) awards is determined based on the market price of Agilents common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (OM) reflects the cost of awards that are probable to vest at the end of the performance period. All awards granted in 2016 to our senior management employees have a one year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employee were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the 3 year average historical stock price volatility of a group of our peer companies and an expected dividend yield to compute the discount. The grants made during 2016 have a discount of 5.5 percent while computing the fair value.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "INCOME TAXES (Notes)", 
        "Income Tax Disclosure [Abstract]": {
            "INCOME TAXES": {
                "value": " 5. INCOME TAXES The companys effective tax rate from continuing operations was 22.2 percent and 17.4 percent for the three and six months ended April 30, 2016 , respectively. The companys effective tax rate from continuing operations was 4.2 percent and 11.5 percent for the three and six months ended April 30, 2015 , respectively. The income tax expense from continuing operations was $26 million and $45 million for the three and six months ended April 30, 2016 , respectively. The income tax expense from continuing operations was $4 million and $24 million for the three and six months ended April 30, 2015 , respectively. The income tax provision from continuing operations for the three and six months ended April 30, 2016 included net discrete tax expense of $3 million and tax benefit of $3 million , respectively. The net discrete tax expense for the three months ended April 30, 2016 included a tax expense of $7 million for return-to-provision adjustments associated with the filing of the return in Germany, $5 million of which was determined to be out of period. The remaining discrete items in the quarter include an $8 million tax benefit related to the realization of tax credits that reduce the deferred tax liability for unremitted foreign earnings, $2 million tax expense of other miscellaneous return-to-provision adjustments in other foreign jurisdictions and $2 million of miscellaneous other discrete tax expense. The out of period adjustment is a true up of a deferred tax asset related to a net operating loss carryover that was recorded in 2006 using an incorrect income tax rate. In addition to the aforementioned, the net discrete tax benefit for the six months ended April 30, 2016 included $5 million of tax benefit for the extension, which occurred in the first quarter of 2016, of the U.S. research and development tax credit attributable to the company's prior fiscal year, and $6 million of tax expense related to the curtailment gain recognized with respect to the U.S. retirement plan and Supplemental Benefits Plan. The net discrete tax benefit for the six months ended April 30, 2016 also included $9 million of tax benefit related primarily to return-to-provision adjustments in Singapore and $2 million of other discrete tax expense items. The out of period adjustment is not considered to be material to current or prior periods. The income tax provision from continuing operations for the three and six months ended April 30, 2015 included net discrete benefits of $13 million and $16 million , respectively. The net discrete tax benefit for the three months ended April 30, 2015 included $16 million of tax benefit related to the de-registration of certain foreign branches, and $3 million of other discrete tax expense. In addition to the aforementioned, the net discrete tax benefit for the six months ended April 30, 2015 included $6 million of tax benefit for the extension, which occurred in the first quarter of 2015, of the U.S. research and development tax credit attributable to the company's prior fiscal year and $3 million of other discrete tax expense items. In the U.S., tax years remain open back to the year 2012 for federal income tax purposes and the year 2000 for significant states. On September 22, 2015, we reached an agreement with the Internal Revenue Service (\"IRS\") for the tax years 2008 through 2011. During the first quarter of 2016, we made a payment of approximately $9 million of tax plus interest as part of closing the exam. In 2015, we reclassified a portion of other long-term liabilities to other accrued liabilities related to uncertain tax positions of continuing operations that we expected to pay within the next twelve months. This amount was partially offset by a prepaid tax account of approximately $3 million that the IRS allowed as an offset to the $12 million in incremental taxes. The settlement resulted in the recognition, within the continuing operations, of previously unrecognized tax benefits of $119 million , offset by a tax liability on foreign distributions of approximately $99 million principally related to the repatriation of foreign earnings. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2003. With these jurisdictions and the U.S., it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits. On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. v. Commissioner related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. A final decision was entered by the U.S. Tax Court on December 1, 2015. At this time, the U.S. Department of the Treasury has not withdrawn the requirement from its regulations to include stock-based compensation in an intercompany cost-sharing arrangement. The IRS notified the U.S. Court of Appeals for the Ninth Circuit on February 19, 2016 of its intent to appeal the Tax Court's decision in the case. We concluded that no adjustment to our consolidated financial statements is appropriate at this time due to the uncertainties with respect to the ultimate resolution of this case.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "NET INCOME PER SHARE (Notes)", 
        "Earnings Per Share [Abstract]": {
            "NET INCOME PER SHARE": {
                "value": "6. NET INCOME PER SHARE The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 (As Revised) 2016 2015 (As Revised) (in millions) Numerator: Income from continuing operations $ 91 $ 92 $ 214 $ 185 Loss from discontinued operations  (5 )  (35 ) Net income $ 91 $ 87 $ 214 $ 150 Denominator: Basic weighted-average shares 326 334 327 335 Potential common shares stock options and other employee stock plans 2 3 3 2 Diluted weighted-average shares 328 337 330 337 The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense, the tax benefits or shortfalls recorded to additional paid-in capital and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense and tax benefits or shortfalls collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards. We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. For the three and six months ended April 30, 2016 , 2.1 million and 1.7 million options to purchase shares were excluded from the calculation of diluted earnings per share, respectively. For the three and six months ended April 30, 2015 , 66,200 and 672,500 options to purchase shares were excluded from the calculation of diluted earnings per share, respectively. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price, unamortized fair value and excess tax benefits or shortfalls collectively were greater than the average market price of our common stock because their effect would also be anti-dilutive. For the three and six months ended April 30, 2016 , 2,600 and 3,500 additional shares were excluded from the calculation of diluted earnings per share, respectively. For the three and six months ended April 30, 2015 , 1.4 million and 690,200 additional shares were excluded from the calculation of diluted earnings per share, respectively.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "INVENTORY (Notes)", 
        "Inventory, Net [Abstract]": {
            "INVENTORY": {
                "value": "7. INVENTORY April 30, October 31, (in millions) Finished goods $ 367 $ 362 Purchased parts and fabricated assemblies 188 179 Inventory $ 555 $ 541", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)", 
        "Goodwill and Intangible Assets Disclosure [Abstract]": {
            "GOODWILL AND OTHER INTANGIBLE ASSETS": {
                "value": "8. GOODWILL AND OTHER INTANGIBLE ASSETS The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2016 : Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Goodwill as of October 31, 2015 $ 650 $ 1,234 $ 482 $ 2,366 Foreign currency translation impact 5 44 4 53 Goodwill arising from acquisitions 137   137 Goodwill as of April 30, 2016 $ 792 $ 1,278 $ 486 $ 2,556 The components of other intangibles as of April 30, 2016 and October 31, 2015 are shown in the table below: Purchased Other Intangible Assets Gross Carrying Amount Accumulated Amortization and Impairments Net Book Value (in millions) As of October 31, 2015: Purchased technology $ 746 $ 476 $ 270 Trademark/Tradename 141 50 91 Customer relationships 230 168 62 Total amortizable intangible assets 1,117 694 423 In-Process R&D 22  22 Total $ 1,139 $ 694 $ 445 As of April 30, 2016: Purchased technology 840 535 305 Backlog 1 1  Trademark/Tradename 154 57 97 Customer relationships 266 200 66 Total amortizable intangible assets 1,261 793 468 In-Process R&D 22  22 Total $ 1,283 $ 793 $ 490 On November 1, 2015, we acquired Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics, for $242 million . The acquisition accounting for Seahorse was completed in the second quarter resulting in a $3 million adjustment to decrease goodwill. As a result, we recorded additions to goodwill of $137 million and additions to other intangible assets of $118 million during the six months ended April 30, 2016 . During the six months ended April 30, 2016 , other intangible assets increased $10 million , due to the impact of foreign exchange translation. Amortization expense of intangible assets was $40 million and $83 million for the three and six months ended April 30, 2016 , respectively. Amortization expense of intangible assets was $38 million and $81 million for the three and six months ended April 30, 2015 , respectively. Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2016 and for each of the five succeeding fiscal years and thereafter is estimated below: Estimated future amortization expense: (in millions) Remainder of 2016 $ 69 2017 $ 113 2018 $ 83 2019 $ 59 2020 $ 48 2021 $ 36 Thereafter $ 60", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "FAIR VALUE MEASUREMENTS (Notes)", 
        "Fair Value Disclosures [Abstract]": {
            "FAIR VALUE MEASUREMENTS": {
                "value": "9. FAIR VALUE MEASUREMENTS The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instruments categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value: Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Financial assets and liabilities measured at fair value on a recurring basis as of April 30, 2016 were as follows: Fair Value Measurement at April 30, 2016 Using April 30, Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in millions) Assets: Short-term Cash equivalents (money market funds) $ 1,454 $ 1,454 $  $  Derivative instruments (foreign exchange contracts) 3  3  Long-term Trading securities 30 30   Total assets measured at fair value $ 1,487 $ 1,484 $ 3 $  Liabilities: Short-term Derivative instruments (foreign exchange and interest rate swap contracts) $ 13 $  $ 13 $  Long-term Deferred compensation liability 30  30  Total liabilities measured at fair value $ 43 $  $ 43 $  Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2015 were as follows: Fair Value Measurement at October 31, 2015 Using October 31, Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in millions) Assets: Short-term Cash equivalents (money market funds) $ 1,411 $ 1,411 $  $  Derivative instruments (foreign exchange contracts) 4  4  Long-term Trading securities 35 35   Total assets measured at fair value $ 1,450 $ 1,446 $ 4 $  Liabilities: Short-term Derivative instruments (foreign exchange contracts) $ 5 $  $ 5 $  Long-term Deferred compensation liability 35  35  Total liabilities measured at fair value $ 40 $  $ 40 $  Our money market funds and trading securities investments are generally valued using quoted market prices and therefore are classified within level 1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets. Our deferred compensation liability is classified as level 2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive loss within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income. Impairment of Investments. There were no impairments of investments for the three and six months ended April 30, 2016 and 2015 . Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis For the three and six months ended April 30, 2016 and 2015 , there were no impairments of long-lived assets held and used. For the three and six months ended April 30, 2016 and 2015 , there were no impairments of long-lived assets held for sale.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "DERIVATIVES (Notes)", 
        "Derivative Instruments and Hedging Activities Disclosure [Abstract]": {
            "DERIVATIVES": {
                "value": "10. DERIVATIVES We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts, purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates. Fair Value Hedges We are exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars at fixed interest rates based on the market conditions at the time of financing. The fair value of our fixed rate debt changes when the underlying market rates of interest change, and, in the past, we have used interest rate swaps to change our fixed interest rate payments to U.S. dollar LIBOR-based variable interest expense to match the floating interest income from our cash, cash equivalents and other short term investments. As of April 30, 2016 , all interest rate swap contracts had either been terminated or had expired. On November 25, 2008, we terminated two interest rate swap contracts associated with our 2017 senior notes that represented the notional amount of $400 million . On October 20, 2014 we prepaid $500 million out of $600 million principal of our 2017 senior notes and fully amortized the associated proportionate deferred gain to other income (expense). The remaining gain to be amortized related to the $100 million of 2017 senior notes at April 30, 2016 was $1 million . On August 9, 2011, we terminated five interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million . The remaining gain to be amortized at April 30, 2016 was $17 million . All deferred gains from terminated interest rate swaps are being amortized over the remaining life of the respective senior notes. Cash Flow Hedges We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. Changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in other income (expense) each period. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense) in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense) in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in other income (expense) over the life of the option contract. Ineffectiveness in the three and six months ended April 30, 2016 and 2015 was not significant. For the three and six months ended April 30, 2016 and 2015 gains and losses recognized in other income (expense) due to de-designation of cash flow hedge contracts were not significant. In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at April 30, 2016 was $2 million . In February 2016, Agilent executed three forward-starting interest rate swaps for the notional amount of $300 million in connection with future interest payments associated with the planned issuance of debt later this fiscal year. The contract term allows us to lock-in a treasury rate on our anticipated debt issuance. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance. The changes in fair value of these derivative instruments will be recognized in accumulated other comprehensive income (loss). For both the three months and six months ended April 30, 2016, a loss of $3 million was recognized in accumulated other comprehensive income (loss). Amounts associated with these cash flow hedges will be reclassified to interest expense in the condensed consolidated statement of operations when the forecasted future interest payments on the debt occur. Other Hedges Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative are recognized in other income (expense) in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities. Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors. We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties. A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions. The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of April 30, 2016 , was $10 million . The credit-risk-related contingent features underlying these agreements had not been triggered as of April 30, 2016 . There were 62 foreign exchange forward contracts open as of April 30, 2016 and designated as cash flow hedges. There were 158 foreign exchange forward contracts open as of April 30, 2016 not designated as hedging instruments. The aggregated notional amounts by currency and designation as of April 30, 2016 were as follows: Derivatives Designated as Cash Flow Hedges Derivatives Not Designated as Hedging Instruments Forward Contracts USD Forward Contracts USD Forward Contracts DKK Currency Buy/(Sell) Buy/(Sell) Buy/(Sell) (in millions) Euro $ (31 ) $ 116 $ (56 ) British Pound (31 ) (4 ) (4 ) Canadian Dollar (27 ) (2 ) (3 ) Australian Dollar 3 14 (4 ) Malaysian Ringgit  (2 )  Japanese Yen (65 ) 21 (1 ) American Dollar   44 Other (5 ) 39 (14 ) Totals $ (156 ) $ 182 $ (38 ) Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of April 30, 2016 and October 31, 2015 were as follows: Fair Values of Derivative Instruments Asset Derivatives Liability Derivatives Fair Value Fair Value Balance Sheet Location April 30, October 31, Balance Sheet Location April 30, October 31, (in millions) Derivatives designated as hedging instruments: Cash flow hedges Foreign exchange forward contracts $ 1 $ 2 $ 8 $ 1 Interest rate swap contracts   3  Other current assets $ 1 $ 2 Other accrued liabilities $ 11 $ 1 Derivatives not designated as hedging instruments: Foreign exchange contracts Other current assets $ 2 $ 2 Other accrued liabilities $ 2 $ 4 Total derivatives $ 3 $ 4 $ 13 $ 5 The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Derivatives designated as hedging instruments: Cash Flow Hedges Foreign exchange contracts: Gain (loss) recognized in accumulated other comprehensive income (loss) $ (10 ) $ (2 ) $ (6 ) $ 8 Gain reclassified from accumulated other comprehensive income (loss) into cost of sales $ 1 $ 7 $ 2 $ 11 Interest rate swap contracts: Loss recognized in accumulated other comprehensive income (loss) $ (3 ) $  $ (3 ) $  Derivatives not designated as hedging instruments: Gain (loss) recognized in other income (expense) $ 5 $ (4 ) $ 3 $ (17 ) The estimated amount of existing net loss at April 30, 2016 that is expected to be reclassified from other comprehensive income (loss) to cost of sales within the next twelve months is $7 million .", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)", 
        "Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]": {
            "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS": {
                "value": "1. RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Components of net periodic costs. For the three and six months ended April 30, 2016 and 2015 , our net pension and post retirement benefit costs were comprised of the following: Pensions U.S. Plans Non-U.S. Plans U.S. Post Retirement Benefit Plans Three Months Ended April 30, 2016 2015 2016 2015 2016 2015 (in millions) Service costbenefits earned during the period $ 6 $ 6 $ 5 $ 4 $  $ 1 Interest cost on benefit obligation 4 3 4 6 1 1 Expected return on plan assets (6 ) (7 ) (11 ) (10 ) (1 ) (2 ) Amortization: Actuarial losses  1 7 6 2 1 Prior service cost (1 ) (1 )   (3 ) (3 ) Total net plan costs $ 3 $ 2 $ 5 $ 6 $ (1 ) $ (2 ) Curtailments and settlements $  Pensions U.S. Plans Non-U.S. U.S. Post Retirement Six Months Ended April 30, 2016 2015 2016 2015 2016 2015 (in millions) Service costbenefits earned during the period $ 12 $ 12 $ 9 $ 8 $  $ 2 Interest cost on benefit obligation 7 7 8 12 2 2 Expected return on plan assets (12 ) (14 ) (22 ) (21 ) (3 ) (4 ) Amortization: Actuarial losses 2 2 14 13 5 2 Prior service cost (2 ) (2 )   (5 ) (6 ) Total net plan costs $ 7 $ 5 $ 9 $ 12 $ (1 ) $ (4 ) Curtailment and settlements (16 ) We contributed zero to our U.S. defined benefit plans during both the three and six months ended April 30, 2016 . We contributed $9 million and $13 million to our non-U.S. defined benefit plans during the three and six months ended April 30, 2016 , respectively. We contributed $15 million to our U.S. defined benefit plans during both the three and six months ended April 30, 2015 . We contributed $6 million and $11 million to our non-U.S. defined benefit plans during the three and six months ended April 30, 2015 , respectively. We do not expect to contribute to our U.S. defined benefit plans during the remainder of 2016 and we expect to contribute $12 million to our non-U.S. defined benefit plans during the remainder of 2016 . Plan Amendments. During the three months ended January 31, 2016, we made changes to our U.S. Retirement Plan and Supplemental Benefits Retirement Plan (\"U.S. Plans\"). Effective April 30, 2016, benefit accruals under the U.S. Plans will be frozen. Any pension benefit earned in the U.S. Plans through April 30, 2016 will remain fully vested, but there will be no additional benefit accruals after April 30, 2016. In addition, active employees who have not met the eligibility requirement for the Retiree Medical Account (RMA) under the U.S. Post Retirement Benefit Plan - 55 years old with at least 15 years of Agilent service - as of April 30, 2016 - will only be eligible for 50 percent of the current RMA reimbursement amount upon retirement. Due to these plan amendments, we recorded a curtailment gain of $15 million in the U.S. Plans during the six months ended April 30, 2016 . In addition, we recognized a settlement gain of $1 million related to the U.S. Supplemental Benefits Retirement Plan during the six months ended April 30, 2016 .", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "WARRANTIES AND CONTINGENCIES (Notes)", 
        "Commitments and Contingencies Disclosure [Abstract]": {
            "WARRANTIES AND CONTINGENCIES": {
                "value": "12. WARRANTIES AND CONTINGENCIES Warranties We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product shipments. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product. A summary of the standard warranty accrual activity is shown in the table below: Six Months Ended April 30, 2016 2015 (in millions) Beginning balance as of November 1 $ 31 $ 30 Accruals for warranties including change in estimate 33 22 Settlements made during the period (27 ) (24 ) Ending balance as of April 30 $ 37 $ 28 Accruals for warranties due within one year $ 36 $ 26 Accruals for warranties due after one year 1 2 Ending balance as of April 30 $ 37 $ 28 Contingencies We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are probable of having a material impact to our business, consolidated financial condition, results of operations or cash flows.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "SHORT-TERM DEBT (Notes)", 
        "Short-term Debt [Abstract]": {
            "SHORT-TERM DEBT": {
                "value": "13. SHORT-TERM DEBT Credit Facilities On September 15, 2014 , Agilent entered into a credit agreement with a group of financial institutions which provides for a $400 million five -year unsecured credit facility that will expire on September 15, 2019 . On June 9, 2015, the commitments under the existing credit facility were increased by $300 million so that the aggregate commitments under the facility now total $700 million . As of April 30, 2016 , the company had borrowings of $235 million outstanding under the facility. We were in compliance with the covenants for the credit facility during the three and six months ended April 30, 2016 .", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "LONG-TERM DEBT (Notes)", 
        "Debt Disclosure [Abstract]": {
            "LONG-TERM DEBT": {
                "value": "14. LONG-TERM DEBT Senior Notes The following table summarizes the companys long-term senior notes and the related interest rate swaps: April 30, 2016 October 31, 2015 Amortized Principal Swap Total Amortized Principal Swap Total (in millions) 2017 Senior Notes $ 100 $ 1 $ 101 $ 100 $ 2 $ 102 2020 Senior Notes 499 17 516 499 19 518 2022 Senior Notes 399  399 399  399 2023 Senior Notes 598  598 598  598 Total $ 1,596 $ 18 $ 1,614 $ 1,596 $ 21 $ 1,617 All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilents other senior unsecured indebtedness. There have been no changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the six months ended April 30, 2016 as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 . All swap contracts have been terminated and amounts to be amortized over the remaining life of the senior notes as of April 30, 2016 and October 31, 2015 are detailed above. Other Debt As of April 30, 2016 and October 31, 2015 , we have mortgage debt, secured on buildings in Denmark, in Danish Krone equivalent of $40 million and $38 million , respectively, aggregate principal, outstanding with a Danish financial institution.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "STOCKHOLDERS' EQUITY (Notes)", 
        "Stockholders' Equity Note [Abstract]": {
            "STOCKHOLDERS EQUITY": {
                "value": "15. STOCKHOLDERS' EQUITY Stock Repurchase Program On November 22, 2013 we announced that our board of directors had authorized a share repurchase program effective in the first quarter of fiscal year 2014, upon the conclusion of the company's previous $1 billion repurchase program. The program was designed to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs to target maintaining a weighted average share count of approximately 335 million diluted shares. During the six months ended April 30, 2016 , we repurchased approximately 2.4 million shares for $98 million , which completed the purchases under this authorization. All such shares and related costs are held as treasury stock and accounted for using the cost method. For the six months ended April 30, 2015 , we repurchased 4 million shares for $168 million under this plan. On May 28, 2015 we announced that our board of directors had approved a new share repurchase program (the \"2015 repurchase program\"). The 2015 repurchase program authorizes the purchase of up to $1.14 billion of our common stock through and including November 1, 2018. The 2015 repurchase program does not require the company to acquire a specific number of shares and may be suspended or discontinued at any time. During the three and six months ended April 30, 2016 , upon the completion of our previous repurchase program, we repurchased approximately 2.6 million shares for $94 million and 5.1 million shares for $196 million , respectively, under this authorization. All such shares and related costs are held as treasury stock and accounted for using the cost method. As of April 30, 2016 , we had remaining authorization to repurchase up to $944 million of our common stock under this program. Cash Dividends on Shares of Common Stock During the three and six months ended April 30, 2016 , we paid cash dividends of $0.115 per common share or $37 million and $0.230 per common share or $75 million on the company's common stock. During the three and six months ended April 30, 2015 , we paid cash dividends of $0.100 per common share or $33 million and $0.200 per common share or $67 million on the company's common stock. On May 18, 2016 our board of directors declared a quarterly cash dividend of $0.115 per share of common stock, or approximately $37 million which will be paid on July 27, 2016 to all shareholders of record at close of business on July 5, 2016 . The timing and amounts of any future dividends are subject to determination and approval by our board of directors. Accumulated Other Comprehensive Income (Loss) Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions): Net defined benefit pension cost and post retirement plan costs Three Months Ended April 30, 2016 Foreign currency translation Prior service credits Actuarial Losses Unrealized gains (losses) on derivatives Total (in millions) As of January 31, 2016 $ (245 ) $ 153 $ (350 ) $ 4 $ (438 ) Other comprehensive income (loss) before reclassifications 153   (13 ) 140 Amounts reclassified out of accumulated other comprehensive income (loss)  (4 ) 9 (1 ) 4 Tax (expense) benefit (8 ) 1 (3 ) 5 (5 ) Other comprehensive income (loss) 145 (3 ) 6 (9 ) 139 As of April 30, 2016 $ (100 ) $ 150 $ (344 ) $ (5 ) $ (299 ) Six Months Ended April 30, 2016 As of October 31, 2015 $ (189 ) $ 161 $ (365 ) $ 2 $ (391 ) Other comprehensive income (loss) before reclassifications 96 6 6 (9 ) 99 Amounts reclassified out of accumulated other comprehensive income (loss)  (23 ) 22 (2 ) (3 ) Tax (expense) benefit (7 ) 6 (7 ) 4 (4 ) Other comprehensive income (loss) 89 (11 ) 21 (7 ) 92 As of April 30, 2016 $ (100 ) $ 150 $ (344 ) $ (5 ) $ (299 ) Reclassifications out of accumulated other comprehensive income (loss) for the three and six months ended April 30, 2016 and 2015 were as follows (in millions): Details about accumulated other Amounts Reclassified Affected line item in comprehensive income (loss) components from other comprehensive income (loss) statement of operations Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 Unrealized gains and (losses) on derivatives $ 1 $ 7 $ 2 $ 11 Cost of products 1 7 2 11 Total before income tax (1 ) (2 ) (1 ) (3 ) Provision for income tax  5 1 8 Total net of income tax Net defined benefit pension cost and post retirement plan costs: Actuarial net loss (9 ) (8 ) (22 ) (17 ) Prior service benefit 4 4 23 8 (5 ) (4 ) 1 (9 ) Total before income tax 2 1 (2 ) 1 (Provision) benefit for income tax (3 ) (3 ) (1 ) (8 ) Total net of income tax Total reclassifications for the period $ (3 ) $ 2 $  $  Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss). Reclassifications out of accumulated other comprehensive income (loss) of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost together with curtailments and settlements (see Note 11 \"Retirement Plans and Post Retirement Pension Plans\").", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "SEGMENT INFORMATION (Notes)", 
        "Segment Reporting [Abstract]": {
            "SEGMENT INFORMATION": {
                "value": "16. SEGMENT INFORMATION Description of segments. We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Agilent has three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business each of which comprises a reportable segment. The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments. A description of our three reportable segments is as follows: Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Key product categories include: liquid chromatography (\"LC\") systems and components; liquid chromatography mass spectrometry (\"LCMS\") systems; gas chromatography (\"GC\") systems and components; gas chromatography mass spectrometry (\"GCMS\") systems; inductively coupled plasma mass spectrometry (\"ICP-MS\") instruments; atomic absorption (\"AA\") instruments; microwave plasma-atomic emission spectrometry (MP-AES) instruments; inductively coupled plasma optical emission spectrometry (\"ICP-OES\") instruments; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our diagnostics and genomics business is comprised of three areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing (\"NGS\") target enrichment. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices (\"GMP\") conditions for use as active pharmaceutical ingredients (\"API\") in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Finally, our pathology solutions business is focused on product offerings to cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining and special staining. We also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. The majority of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements. A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, other corporate infrastructure expenses and costs of centralized research and development. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, pension curtailment gain, restructuring and transformational expenses, acquisition and integration costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments. The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below. Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Three months ended April 30, 2016: Total net revenue $ 495 $ 178 $ 346 $ 1,019 Segment income from operations $ 94 $ 27 $ 74 $ 195 Three months ended April 30, 2015: Total net revenue $ 473 $ 169 $ 321 $ 963 Segment income from operations $ 75 $ 25 $ 69 $ 169 Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Six months ended April 30, 2016: Total net revenue $ 1,021 $ 336 $ 690 $ 2,047 Segment income from operations $ 208 $ 42 $ 150 $ 400 Six months ended April 30, 2015: Total net revenue $ 1,020 $ 317 $ 652 $ 1,989 Segment income from operations $ 182 $ 26 $ 137 $ 345 The following table reconciles reportable segments income from operations to Agilents total enterprise income before taxes: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Total reportable segments income from operations $ 195 $ 169 $ 400 $ 345 Acceleration of share-based compensation related to workforce reduction  (1 )  (2 ) Transformational initiatives (10 ) (17 ) (21 ) (29 ) Amortization of intangibles (40 ) (38 ) (83 ) (81 ) Acquisition and integration costs (12 ) (1 ) (17 ) (2 ) Business exit and divestiture costs (primarily our NMR business) (1 ) (8 ) (6 ) (11 ) Pension curtailment gain   16  Other (1 ) 3 (3 ) 2 Interest income 3 2 5 4 Interest expense (18 ) (17 ) (36 ) (33 ) Other income (expense), net 1 4 4 16 Income from continuing operations before taxes, as reported $ 117 $ 96 $ 259 $ 209 The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, including deferred tax assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets. Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Assets: As of April 30, 2016 $ 1,699 $ 2,052 $ 1,062 $ 4,813 As of October 31, 2015 $ 1,539 $ 2,027 $ 1,008 $ 4,574", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", 
        "Accounting Policies [Abstract]": {
            "Overview, Segment Structure and Basis of Presentation": {
                "value": "Overview. Agilent Technologies, Inc. (\"we\", \"Agilent\" or the \"company\"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Our fiscal year-end is October 31, and our fiscal quarters end on January 31, April 30 and July 31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters. Basis of Presentation . We have prepared the accompanying financial data for the three and six months ended April 30, 2016 and 2015 pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (GAAP) in the U.S. have been condensed or omitted pursuant to such rules and regulations. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 . In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of April 30, 2016 and October 31, 2015 , condensed consolidated statement of comprehensive income (loss) for the three and six months ended April 30, 2016 and 2015 , condensed consolidated statement of operations for the three and six months ended April 30, 2016 and 2015 , and condensed consolidated statement of cash flows for the six months ended April 30, 2016 and 2015 .", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Reclassification": {
                "value": "Revision of Services and Other and Product Net Revenues and related Cost of Sales. In 2015, we revised amounts shown in our condensed consolidated statement of operations to more accurately reflect the character of items delivered to customers. Our diagnostic and genomics segment identified a stream of service revenues that had been presented as product revenue in the prior year. We have now revised prior year's presentation to show the revenue within services and other. The cost of sales associated with these newly identified service revenues has also been revised to align with the new presentation. For the three and six months ended April 30, 2015 services and other revenue increased $9 million and $15 million and services and other cost of sales increased $6 million and $11 million with corresponding reductions in product revenue and cost of sales. These corrections to the classifications are not considered to be material to current or prior periods and had no impact to our results of operations previously reported in our condensed consolidated statement of operations. ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Use of Estimates": {
                "value": "Use of Estimates. The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on managements best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, share-based compensation, retirement and post-retirement plan assumptions and accounting for income taxes.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Variable Interest Entity Disclosure": {
                "value": "Variable Interest Entities. We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (VIE). The company evaluates its investments in privately held companies on an ongoing basis. We have determined that as of April 30, 2016 there were no VIEs required to be consolidated in the companys consolidated financial statements because we do not have a controlling financial interest in any of the VIEs that we have invested in. We account for these investments under either the equity or cost method, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure. As of April 30, 2016, the carrying value of our investments in VIEs was $103 million with a maximum exposure of $109 million which includes our loans to our investments. The investments are included on the long term investments line of the condensed consolidated balance sheet. During the three months ended April 30, 2016, Agilent made a preferred stock investment in Lasergen for $80 million . Agilents initial ownership stake was 48 percent and we have also joined the board of Lasergen and signed a collaboration agreement. We have the option to acquire all of the remaining shares of Lasergen until March 2, 2018, for an additional consideration of $105 million . Lasergen is a VIE, however, we do not consolidate the entity in our financial statements because we do not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance. Because Agilent owns preferred stock of Lasergen, we account for this investment under the cost method. As of April 30, 2016, both the carrying value and maximum exposure of the Lasergen investment was $80 million . The maximum exposure is equal to the carrying value because we do not have future funding commitments. ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Fair Value of Financial Instruments": {
                "value": "Fair Value of Financial Instruments. The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments is determined using quoted market prices for those securities when available. For those long-term equity investments accounted for under the cost or equity method, their carrying value approximates their estimated fair value. Equity method investments are reported at the amount of the companys initial investment and adjusted each period for the companys share of the investees income or loss and dividend paid. The fair value of our long-term debt, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy, exceeds the carrying value by approximately $87 million and $30 million as of April 30, 2016 and October 31, 2015 , respectively. The change in the excess of fair value over carrying value in the six months ended April 30, 2016 is due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 9, \"Fair Value Measurements\" for additional information on the fair value of financial instruments.", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Goodwill and Purchased Intangible Assets": {
                "value": "Goodwill and Purchased Intangible Assets. Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required. The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers. If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units. In fiscal year 2015, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a quantitative test for goodwill impairment of the three reporting units, as of September 30, 2015. Based on the results of our testing, the fair value of these reporting units are greater than their respective carrying values. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the three and six months ended April 30, 2016 and 2015 . Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years . In-process research and development (\"IPR&D\") is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's condensed consolidated statement of operations in the period it is abandoned. Agilent's indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2015. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets is indicated. There were no indicators of impairment of indefinite-lived intangible assets during the three and six months ended April 30, 2016 and 2015 . ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)", 
        "Income Tax Disclosure [Abstract]": {
            "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]": {
                "value": "For the three and six months ended April 30, 2016, we are presenting comparative fiscal 2015 quarterly information. The fiscal 2015 results for the three and six months ended April 30, 2015 have been revised to reflect the quarterly impact of the out of period adjustments described above. For the three months ended April 30, 2015 the following out of period adjustments were included in the as-reported column in the revision adjustment table and have been removed in the adjustments column: $4 million of tax expense related to the increase of foreign deferred tax liabilities for a prior year. In addition to the aforementioned, for the six months ended April 30, 2015, the following out of period adjustments were included in the as-reported column in the revision adjustment table and have been removed in the adjustments column: $13 million of tax benefit from the reduction in deferred tax liabilities due to tax rate changes in Denmark occurring in a prior year and $4 million of tax expense attributable to an error discovered on a prior year U.S. tax return. Three Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions, except per share data) Income from continuing operations before taxes $ 96 $ 96 Provision for income taxes 8 (4 ) 4 Income from continuing operations 88 92 Loss from discontinued operations, net of tax benefit of $0 million (5 ) (5 ) Net Income $ 83 $ 4 $ 87 Net income per share - basic Income from continuing operations $ 0.26 $ 0.28 Loss from discontinued operations (0.01 ) (0.02 ) Net income per share - basic $ 0.25 $ 0.26 Net income per share - diluted Income from continuing operations $ 0.26 $ 0.27 Loss from discontinued operations (0.01 ) (0.01 ) Net income per share - diluted $ 0.25 $ 0.26 Total comprehensive income $ 74 $ 4 $ 78 Six Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions, except per share data) Income from continuing operations before taxes $ 209 $ 209 Provision for income taxes 19 5 24 Income from continuing operations 190 185 Loss from discontinued operations, net of tax benefit of $2 (35 ) (35 ) Net Income $ 155 $ (5 ) $ 150 Net income per share - basic Income from continuing operations $ 0.57 $ 0.55 Loss from discontinued operations (0.11 ) (0.10 ) Net income per share - basic $ 0.46 $ 0.45 Net income per share - diluted Income from continuing operations $ 0.56 $ 0.55 Loss from discontinued operations (0.10 ) (0.10 ) Net income per share - diluted $ 0.46 $ 0.45 Total comprehensive loss $ (113 ) $ (5 ) $ (118 ) The adjustments resulted in the following revisions to our condensed consolidated statement of cash flow. Six Months Ended April 30, 2015 As Reported Adjustments As Revised (in millions) Net income $ 155 $ (5 ) $ 150 Deferred taxes $ (3 ) $ 7 $ 4 Changes in assets and liabilities: Other assets and liabilities $ (127 ) $ (2 ) $ (129 ) Net cash provided by operating activities $ 163 $  $ 163", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "SHARE-BASED COMPENSATION (Tables)", 
        "Share-based Compensation [Abstract]": {
            "Allocated Share-based compensation expense disclosure": {
                "value": "The impact on our results for share-based compensation was as follows: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Cost of products and services $ 3 $ 2 $ 9 $ 7 Research and development 1 1 3 3 Selling, general and administrative 10 9 25 24 Total share-based compensation expense $ 14 $ 12 $ 37 $ 34 ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Assumptions used to estimate fair value for stock options and LTPP": {
                "value": "The following assumptions were used to estimate the fair value of the options and LTPP grants. Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 Stock Option Plans: Weighted average risk-free interest rate  1.5%  1.7 % Dividend yield  1%  1 % Weighted average volatility  29%  28 % Expected life  5.5yrs  5.5yrs LTPP: Volatility of Agilent shares 24% 25% 24 % 25 % Volatility of selected peer-company shares 14%-50% 12%-57% 14%-50% 12%-57% Price-wise correlation with selected peers 35% 37% 35 % 37 % ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "NET INCOME PER SHARE (Tables)", 
        "Earnings Per Share [Abstract]": {
            "Reconciliation of the numerators and denominators of the basic and diluted net income per share": {
                "value": "The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 (As Revised) 2016 2015 (As Revised) (in millions) Numerator: Income from continuing operations $ 91 $ 92 $ 214 $ 185 Loss from discontinued operations  (5 )  (35 ) Net income $ 91 $ 87 $ 214 $ 150 Denominator: Basic weighted-average shares 326 334 327 335 Potential common shares stock options and other employee stock plans 2 3 3 2 Diluted weighted-average shares 328 337 330 337", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "INVENTORY (Tables)", 
        "Inventory, Net [Abstract]": {
            "INVENTORY": {
                "value": "7. INVENTORY April 30, October 31, (in millions) Finished goods $ 367 $ 362 Purchased parts and fabricated assemblies 188 179 Inventory $ 555 $ 541", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", 
        "Goodwill and Intangible Assets Disclosure [Abstract]": {
            "Goodwill balances and movements for each reportable segments during the period": {
                "value": "The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2016 : Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Goodwill as of October 31, 2015 $ 650 $ 1,234 $ 482 $ 2,366 Foreign currency translation impact 5 44 4 53 Goodwill arising from acquisitions 137   137 Goodwill as of April 30, 2016 $ 792 $ 1,278 $ 486 $ 2,556 ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Components of other intangibles during the period": {
                "value": " The components of other intangibles as of April 30, 2016 and October 31, 2015 are shown in the table below: Purchased Other Intangible Assets Gross Carrying Amount Accumulated Amortization and Impairments Net Book Value (in millions) As of October 31, 2015: Purchased technology $ 746 $ 476 $ 270 Trademark/Tradename 141 50 91 Customer relationships 230 168 62 Total amortizable intangible assets 1,117 694 423 In-Process R&D 22  22 Total $ 1,139 $ 694 $ 445 As of April 30, 2016: Purchased technology 840 535 305 Backlog 1 1  Trademark/Tradename 154 57 97 Customer relationships 266 200 66 Total amortizable intangible assets 1,261 793 468 In-Process R&D 22  22 Total $ 1,283 $ 793 $ 490 ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Schedule of estimated future amortization expense of finite-lived intangible assets": {
                "value": "Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2016 and for each of the five succeeding fiscal years and thereafter is estimated below: Estimated future amortization expense: (in millions) Remainder of 2016 $ 69 2017 $ 113 2018 $ 83 2019 $ 59 2020 $ 48 2021 $ 36 Thereafter $ 60", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "FAIR VALUE MEASUREMENTS (Tables)", 
        "Fair Value Disclosures [Abstract]": {
            "Fair Value Assets And Liabilities Measured On Recurring Basis": {
                "value": "Financial assets and liabilities measured at fair value on a recurring basis as of April 30, 2016 were as follows: Fair Value Measurement at April 30, 2016 Using April 30, Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in millions) Assets: Short-term Cash equivalents (money market funds) $ 1,454 $ 1,454 $  $  Derivative instruments (foreign exchange contracts) 3  3  Long-term Trading securities 30 30   Total assets measured at fair value $ 1,487 $ 1,484 $ 3 $  Liabilities: Short-term Derivative instruments (foreign exchange and interest rate swap contracts) $ 13 $  $ 13 $  Long-term Deferred compensation liability 30  30  Total liabilities measured at fair value $ 43 $  $ 43 $  Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2015 were as follows: Fair Value Measurement at October 31, 2015 Using October 31, Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in millions) Assets: Short-term Cash equivalents (money market funds) $ 1,411 $ 1,411 $  $  Derivative instruments (foreign exchange contracts) 4  4  Long-term Trading securities 35 35   Total assets measured at fair value $ 1,450 $ 1,446 $ 4 $  Liabilities: Short-term Derivative instruments (foreign exchange contracts) $ 5 $  $ 5 $  Long-term Deferred compensation liability 35  35  Total liabilities measured at fair value $ 40 $  $ 40 $ ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "DERIVATIVES (Tables)", 
        "Derivative Instruments and Hedging Activities Disclosure [Abstract]": {
            "Aggregated notional amounts by currency and designation": {
                "value": "The aggregated notional amounts by currency and designation as of April 30, 2016 were as follows: Derivatives Designated as Cash Flow Hedges Derivatives Not Designated as Hedging Instruments Forward Contracts USD Forward Contracts USD Forward Contracts DKK Currency Buy/(Sell) Buy/(Sell) Buy/(Sell) (in millions) Euro $ (31 ) $ 116 $ (56 ) British Pound (31 ) (4 ) (4 ) Canadian Dollar (27 ) (2 ) (3 ) Australian Dollar 3 14 (4 ) Malaysian Ringgit  (2 )  Japanese Yen (65 ) 21 (1 ) American Dollar   44 Other (5 ) 39 (14 ) Totals $ (156 ) $ 182 $ (38 ) ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet": {
                "value": "Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of April 30, 2016 and October 31, 2015 were as follows: Fair Values of Derivative Instruments Asset Derivatives Liability Derivatives Fair Value Fair Value Balance Sheet Location April 30, October 31, Balance Sheet Location April 30, October 31, (in millions) Derivatives designated as hedging instruments: Cash flow hedges Foreign exchange forward contracts $ 1 $ 2 $ 8 $ 1 Interest rate swap contracts   3  Other current assets $ 1 $ 2 Other accrued liabilities $ 11 $ 1 Derivatives not designated as hedging instruments: Foreign exchange contracts Other current assets $ 2 $ 2 Other accrued liabilities $ 2 $ 4 Total derivatives $ 3 $ 4 $ 13 $ 5", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations": {
                "value": "The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Derivatives designated as hedging instruments: Cash Flow Hedges Foreign exchange contracts: Gain (loss) recognized in accumulated other comprehensive income (loss) $ (10 ) $ (2 ) $ (6 ) $ 8 Gain reclassified from accumulated other comprehensive income (loss) into cost of sales $ 1 $ 7 $ 2 $ 11 Interest rate swap contracts: Loss recognized in accumulated other comprehensive income (loss) $ (3 ) $  $ (3 ) $  Derivatives not designated as hedging instruments: Gain (loss) recognized in other income (expense) $ 5 $ (4 ) $ 3 $ (17 ) ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)", 
        "Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]": {
            "Schedule of net pension and post-retirement benefit costs": {
                "value": "Components of net periodic costs. For the three and six months ended April 30, 2016 and 2015 , our net pension and post retirement benefit costs were comprised of the following: Pensions U.S. Plans Non-U.S. Plans U.S. Post Retirement Benefit Plans Three Months Ended April 30, 2016 2015 2016 2015 2016 2015 (in millions) Service costbenefits earned during the period $ 6 $ 6 $ 5 $ 4 $  $ 1 Interest cost on benefit obligation 4 3 4 6 1 1 Expected return on plan assets (6 ) (7 ) (11 ) (10 ) (1 ) (2 ) Amortization: Actuarial losses  1 7 6 2 1 Prior service cost (1 ) (1 )   (3 ) (3 ) Total net plan costs $ 3 $ 2 $ 5 $ 6 $ (1 ) $ (2 ) Curtailments and settlements $  Pensions U.S. Plans Non-U.S. U.S. Post Retirement Six Months Ended April 30, 2016 2015 2016 2015 2016 2015 (in millions) Service costbenefits earned during the period $ 12 $ 12 $ 9 $ 8 $  $ 2 Interest cost on benefit obligation 7 7 8 12 2 2 Expected return on plan assets (12 ) (14 ) (22 ) (21 ) (3 ) (4 ) Amortization: Actuarial losses 2 2 14 13 5 2 Prior service cost (2 ) (2 )   (5 ) (6 ) Total net plan costs $ 7 $ 5 $ 9 $ 12 $ (1 ) $ (4 ) Curtailment and settlements (16 ) ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "WARRANTIES AND CONTINGENCIES (Tables)", 
        "Commitments and Contingencies Disclosure [Abstract]": {
            "Standard warranty": {
                "value": "A summary of the standard warranty accrual activity is shown in the table below: Six Months Ended April 30, 2016 2015 (in millions) Beginning balance as of November 1 $ 31 $ 30 Accruals for warranties including change in estimate 33 22 Settlements made during the period (27 ) (24 ) Ending balance as of April 30 $ 37 $ 28 Accruals for warranties due within one year $ 36 $ 26 Accruals for warranties due after one year 1 2 Ending balance as of April 30 $ 37 $ 28 ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "LONG-TERM DEBT (Tables)", 
        "Debt Disclosure [Abstract]": {
            "Schedule of Senior Notes and Related Interest Rate Swaps": {
                "value": "The following table summarizes the companys long-term senior notes and the related interest rate swaps: April 30, 2016 October 31, 2015 Amortized Principal Swap Total Amortized Principal Swap Total (in millions) 2017 Senior Notes $ 100 $ 1 $ 101 $ 100 $ 2 $ 102 2020 Senior Notes 499 17 516 499 19 518 2022 Senior Notes 399  399 399  399 2023 Senior Notes 598  598 598  598 Total $ 1,596 $ 18 $ 1,614 $ 1,596 $ 21 $ 1,617", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "STOCKHOLDERS' EQUITY (Tables)", 
        "STOCKHOLDERS' EQUITY (Tables)": {
            "Schedule of Accumulated Other Comprehensive Income (Loss)": {
                "value": "Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions): Net defined benefit pension cost and post retirement plan costs Three Months Ended April 30, 2016 Foreign currency translation Prior service credits Actuarial Losses Unrealized gains (losses) on derivatives Total (in millions) As of January 31, 2016 $ (245 ) $ 153 $ (350 ) $ 4 $ (438 ) Other comprehensive income (loss) before reclassifications 153   (13 ) 140 Amounts reclassified out of accumulated other comprehensive income (loss)  (4 ) 9 (1 ) 4 Tax (expense) benefit (8 ) 1 (3 ) 5 (5 ) Other comprehensive income (loss) 145 (3 ) 6 (9 ) 139 As of April 30, 2016 $ (100 ) $ 150 $ (344 ) $ (5 ) $ (299 ) Six Months Ended April 30, 2016 As of October 31, 2015 $ (189 ) $ 161 $ (365 ) $ 2 $ (391 ) Other comprehensive income (loss) before reclassifications 96 6 6 (9 ) 99 Amounts reclassified out of accumulated other comprehensive income (loss)  (23 ) 22 (2 ) (3 ) Tax (expense) benefit (7 ) 6 (7 ) 4 (4 ) Other comprehensive income (loss) 89 (11 ) 21 (7 ) 92 As of April 30, 2016 $ (100 ) $ 150 $ (344 ) $ (5 ) $ (299 )", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Reclassification out of Accumulated Other Comprehensive Income": {
                "value": "Reclassifications out of accumulated other comprehensive income (loss) for the three and six months ended April 30, 2016 and 2015 were as follows (in millions): Details about accumulated other Amounts Reclassified Affected line item in comprehensive income (loss) components from other comprehensive income (loss) statement of operations Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 Unrealized gains and (losses) on derivatives $ 1 $ 7 $ 2 $ 11 Cost of products 1 7 2 11 Total before income tax (1 ) (2 ) (1 ) (3 ) Provision for income tax  5 1 8 Total net of income tax Net defined benefit pension cost and post retirement plan costs: Actuarial net loss (9 ) (8 ) (22 ) (17 ) Prior service benefit 4 4 23 8 (5 ) (4 ) 1 (9 ) Total before income tax 2 1 (2 ) 1 (Provision) benefit for income tax (3 ) (3 ) (1 ) (8 ) Total net of income tax Total reclassifications for the period $ (3 ) $ 2 $  $  ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "SEGMENT INFORMATION (Tables)", 
        "Segment Reporting [Abstract]": {
            "Segment Profitability and Segment Assets": {
                "value": "The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below. Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Three months ended April 30, 2016: Total net revenue $ 495 $ 178 $ 346 $ 1,019 Segment income from operations $ 94 $ 27 $ 74 $ 195 Three months ended April 30, 2015: Total net revenue $ 473 $ 169 $ 321 $ 963 Segment income from operations $ 75 $ 25 $ 69 $ 169 Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Six months ended April 30, 2016: Total net revenue $ 1,021 $ 336 $ 690 $ 2,047 Segment income from operations $ 208 $ 42 $ 150 $ 400 Six months ended April 30, 2015: Total net revenue $ 1,020 $ 317 $ 652 $ 1,989 Segment income from operations $ 182 $ 26 $ 137 $ 345 The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, including deferred tax assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets. Life Sciences and Applied Markets Diagnostics and Genomics Agilent CrossLab Total (in millions) Assets: As of April 30, 2016 $ 1,699 $ 2,052 $ 1,062 $ 4,813 As of October 31, 2015 $ 1,539 $ 2,027 $ 1,008 $ 4,574 ", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Reconciliation of segment results to total enterprise results": {
                "value": "The following table reconciles reportable segments income from operations to Agilents total enterprise income before taxes: Three Months Ended Six Months Ended April 30, April 30, 2016 2015 2016 2015 (in millions) Total reportable segments income from operations $ 195 $ 169 $ 400 $ 345 Acceleration of share-based compensation related to workforce reduction  (1 )  (2 ) Transformational initiatives (10 ) (17 ) (21 ) (29 ) Amortization of intangibles (40 ) (38 ) (83 ) (81 ) Acquisition and integration costs (12 ) (1 ) (17 ) (2 ) Business exit and divestiture costs (primarily our NMR business) (1 ) (8 ) (6 ) (11 ) Pension curtailment gain   16  Other (1 ) 3 (3 ) 2 Interest income 3 2 5 4 Interest expense (18 ) (17 ) (36 ) (33 ) Other income (expense), net 1 4 4 16 Income from continuing operations before taxes, as reported $ 117 $ 96 $ 259 $ 209", 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions", 
        "Variable Interest Entity Disclosures": {
            "Carrying Value of Investments in VIE's": {
                "value": 103, 
                "date": "apr 30 2016"
            }, 
            "Maximum Exposure of investments in VIE's": {
                "value": 109, 
                "date": "apr 30 2016"
            }, 
            "Investment in Lasergen": {
                "value": 80, 
                "date": "mar 02 2016"
            }, 
            "Percentage of Ownership in Lasergen": {
                "value": "48.00%", 
                "date": "mar 02 2016"
            }, 
            "Call option amount to acquire remaining shares of business": {
                "value": 105, 
                "date": "mar 02 2016"
            }
        }, 
        "Fair Value of Financial Instruments": {
            "Fair value of long term debt in excess of carrying value": [
                {
                    "value": 87, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 30, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Goodwill and Purchased Intangible Assets": {
            "Impairment of goodwill": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015"
                }
            ], 
            "Impairment of intangible assets (IPR&D)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Minimum Finite-Lived Intangible Assets": {
            "Purchased intangible assets useful life": {
                "value": "6 months", 
                "date": "apr 30 2016"
            }
        }, 
        "Maximum Finite-Lived Intangible Assets": {
            "Purchased intangible assets useful life": {
                "value": "15 years", 
                "date": "apr 30 2016"
            }
        }, 
        "Services and other revenue Income Statement": {
            "Prior period reclassification adjustment": [
                {
                    "value": 9, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 15, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Services and other cost of sales Income Statement": {
            "Prior period reclassification adjustment": [
                {
                    "value": 6, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015"
                }
            ]
        }
    }, 
    {
        "title": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Details) - USD ($) $ / shares in Units, $ in Millions", 
        "Income Statement": {
            "Income from continuing operations before taxes": [
                {
                    "value": 117, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 96, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 259, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 209, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Provision for income taxes": [
                {
                    "value": 26, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 45, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 24, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income from continuing operations": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 92, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 185, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loss from discontinued operations, net of tax expense benefit of $2": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net income": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 87, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Net income per share - basic": {
            "Income from continuing operations": [
                {
                    "value": 0.26, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 0.57, 
                    "date": "apr 30 2015"
                }
            ], 
            "Loss from discontinued operations": [
                {
                    "value": -0.01, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": -0.11, 
                    "date": "apr 30 2015"
                }
            ], 
            "Net income per share - basic": [
                {
                    "value": 0.25, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 0.46, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Net income per share - diluted": {
            "Deferred income tax adjustment": [
                {
                    "value": 4, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": -7, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Statement of Comprehensive Income": {
            "Total comprehensive income (loss)": [
                {
                    "value": 74, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": -113, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Statement of Cash Flows": {
            "Increase (decrease) in Income taxes payable": {
                "value": -2, 
                "date": "apr 30 2015"
            }, 
            "Impact of tax adjustment to cash from operating activities": {
                "value": 0, 
                "date": "apr 30 2015"
            }
        }, 
        "As Revised Income Statement": {
            "Income from continuing operations before taxes": [
                {
                    "value": 96, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 209, 
                    "date": "apr 30 2015"
                }
            ], 
            "Provision for income taxes": [
                {
                    "value": 4, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 24, 
                    "date": "apr 30 2015"
                }
            ], 
            "Income from continuing operations": [
                {
                    "value": 92, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 185, 
                    "date": "apr 30 2015"
                }
            ], 
            "Loss from discontinued operations, net of tax expense benefit of $2": [
                {
                    "value": -5, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015"
                }
            ], 
            "Net income": [
                {
                    "value": 87, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "As Previously Reported Income Statement": {
            "Income from continuing operations before taxes": [
                {
                    "value": 96, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 209, 
                    "date": "apr 30 2015"
                }
            ], 
            "Provision for income taxes": [
                {
                    "value": 8, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 19, 
                    "date": "apr 30 2015"
                }
            ], 
            "Income from continuing operations": [
                {
                    "value": 88, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 190, 
                    "date": "apr 30 2015"
                }
            ], 
            "Loss from discontinued operations, net of tax expense benefit of $2": [
                {
                    "value": -5, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015"
                }
            ], 
            "Net income": [
                {
                    "value": 83, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 155, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Revision Adjustment Income Statement": {
            "Prior period tax adjustments": [
                {
                    "value": -4, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 5, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Foreign tax rate change [Member] | Revision Adjustment Net income per share - diluted": {
            "Deferred income tax adjustment": {
                "value": -13, 
                "date": "apr 30 2015"
            }
        }, 
        "Due to Error in prior year tax return [Member] | Revision Adjustment Net income per share - diluted": {
            "Tax expense (benefit)": {
                "value": 4, 
                "date": "apr 30 2015"
            }
        }
    }, 
    {
        "title": "SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) - USD ($) $ in Millions", 
        "Share-based Compensation [Abstract]": {
            "Windfall tax benefit realized": [
                {
                    "value": " ", 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": " ", 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]": {
            "Share-based compensation expense": [
                {
                    "value": 14, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 12, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 37, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 34, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Inventory Share-based Compensation, Allocation and Classification in Financial Statements": {
            "Capitalized share-based compensation": [
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "time": "12 months ended", 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Cost of Products and Services Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]": {
            "Share-based compensation expense": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 9, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Research and Development Expense Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]": {
            "Share-based compensation expense": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Selling, General and Administrative Expenses Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]": {
            "Share-based compensation expense": [
                {
                    "value": 10, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 9, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 25, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 24, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "SHARE-BASED COMPENSATION Fair Value Assumptions (Details) shares in Millions", 
        "Share-based Compensation Arrangement by Share-based Payment Award": {
            "Stock options granted | shares": [
                {
                    "value": 0, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended"
                }
            ], 
            "ESPP plan purchase price (in hundredths)": [
                {
                    "value": "85.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "85.00%"
                }, 
                {
                    "value": " ", 
                    "time": "6 months ended"
                }, 
                {
                    "value": " "
                }
            ]
        }, 
        "Stock Options Share-based Compensation Arrangement by Share-based Payment Award": {
            "Weighted average risk-free interest rate (in hundredths)": [
                {
                    "value": "0.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "1.50%"
                }, 
                {
                    "value": "0.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "1.70%"
                }
            ], 
            "Dividend yield": [
                {
                    "value": "0.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "1.00%"
                }, 
                {
                    "value": "0.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "1.00%"
                }
            ], 
            "Weighted average volatility (in hundredths)": [
                {
                    "value": "0.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "29.00%"
                }, 
                {
                    "value": "0.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "28.00%"
                }
            ], 
            "Expected life (in years)": [
                {
                    "value": " ", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "5 years 6 months"
                }, 
                {
                    "value": " ", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "5 years 6 months"
                }
            ], 
            "Number of years of peer groups historical stock price volatility used to determine volatility": [
                {
                    "value": 5.5
                }, 
                {
                    "value": 5.5
                }
            ]
        }, 
        "LTPP Share-based Compensation Arrangement by Share-based Payment Award": {
            "Volatility of Agilent shares (in hundredths)": [
                {
                    "value": "24.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "25.00%"
                }, 
                {
                    "value": "24.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "25.00%"
                }
            ], 
            "Volatility of selected peer-company shares minimum (in hundredths)": [
                {
                    "value": "14.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "12.00%"
                }, 
                {
                    "value": "14.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "12.00%"
                }
            ], 
            "Volatility of selected peer-company shares maximum (in hundredths)": [
                {
                    "value": "50.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "57.00%"
                }, 
                {
                    "value": "50.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "57.00%"
                }
            ], 
            "Price-wise correlation with selected peers (in hundredths)": [
                {
                    "value": "35.00%", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "37.00%"
                }, 
                {
                    "value": "35.00%", 
                    "time": "6 months ended"
                }, 
                {
                    "value": "37.00%"
                }
            ], 
            "Number of years of peer groups historical stock price volatility used to determine volatility": [
                {
                    "value": 3, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 3
                }, 
                {
                    "value": 3, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 3
                }
            ]
        }
    }, 
    {
        "title": "INCOME TAXES (Details) - USD ($) $ in Millions", 
        "Income Tax Disclosure": {
            "Effective Income Tax Rate, Percent": [
                {
                    "value": "22.20%", 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": "4.20%", 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": "17.40%", 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": "11.50%", 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income Tax Expense (Benefit)": [
                {
                    "value": 26, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 45, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 24, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net Discrete Tax Expense (Benefit)": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -13, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -16, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income Taxes Paid": {
                "value": 9, 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Prepaid Taxes": {
                "value": 3, 
                "date": "jan 31 2015"
            }
        }, 
        "Internal Revenue Service": {
            "Incremental taxes": {
                "value": 12, 
                "date": "jan 31 2015"
            }
        }, 
        "Internal Revenue Service (IRS) Internal Revenue Service": {
            "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions": {
                "value": 119, 
                "date": "apr 30 2015"
            }, 
            "Tax liability on foreign earnings distributions": {
                "value": 99, 
                "date": "apr 30 2015"
            }
        }, 
        "U.S. Research & Development Tax Credit Extension Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": [
                {
                    "value": -5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -6, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Pension Curtailment Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": {
                "value": 6, 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Return To Provision Adjustment Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": [
                {
                    "value": 7, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Realization of tax credits [Member] Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": {
                "value": -8, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Miscellaneous Other Return To Provision Adjustment [Member] [Member] Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": {
                "value": 2, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Other Discrete Items Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": [
                {
                    "value": 2, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "De-registration of certain foreign branches [Member] Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": {
                "value": -16, 
                "date": "apr 30 2015"
            }
        }, 
        "Out of Period related to Tax Year 2006 | Return To Provision Adjustment Income Tax Disclosure": {
            "Discrete Tax Expense (Benefit)": {
                "value": 5, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "NET INCOME PER SHARE (Details) - USD ($) $ in Millions", 
        "Numerator:": {
            "Income from continuing operations": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 92, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 185, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Loss from discontinued operations": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -35, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Net income": [
                {
                    "value": 91, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 87, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 214, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Denominators:": {
            "Basic weighted-average shares (in shares)": [
                {
                    "value": 326000000, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 334000000, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 327000000, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 335000000, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Potential common shares - stock options and other employee stock plans (in shares)": [
                {
                    "value": 2000000, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3000000, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 3000000, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2000000, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Diluted weighted average shares (in shares)": [
                {
                    "value": 328000000, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 337000000, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 330000000, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 337000000, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Options with exercise price greater than average market price Antidilutive Securities Excluded from EPS Computation": {
            "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)": [
                {
                    "value": 2100000, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 66200, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1700000, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 672500, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Stock Options, LTPP and restricted stock combined exercise price, unamortized fair value, excess tax benefits or shortfalls greater than average market price Antidilutive Securities Excluded from EPS Computation": {
            "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)": [
                {
                    "value": 2600, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1400000, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 3500, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 690200, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "INVENTORY (Details) - USD ($) $ in Millions", 
        "Inventory, Net [Abstract]": {
            "Finished goods": [
                {
                    "value": 367, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 362, 
                    "date": "oct 31 2015"
                }
            ], 
            "Purchased parts and fabricated assemblies": [
                {
                    "value": 188, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 179, 
                    "date": "oct 31 2015"
                }
            ], 
            "Inventory": [
                {
                    "value": 555, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 541, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details) $ in Millions", 
        "Goodwill Roll Forward": {
            "Goodwill beginning balance": {
                "value": 2366, 
                "time": "6 months ended"
            }, 
            "Foreign currency translation impact": {
                "value": 53, 
                "time": "6 months ended"
            }, 
            "Goodwill arising from acquisitions": {
                "value": 137, 
                "time": "6 months ended"
            }, 
            "Goodwill ending balance": {
                "value": 2556, 
                "time": "6 months ended"
            }
        }, 
        "Life Sciences and Applied Markets Goodwill Roll Forward": {
            "Goodwill beginning balance": {
                "value": 650, 
                "time": "6 months ended"
            }, 
            "Foreign currency translation impact": {
                "value": 5, 
                "time": "6 months ended"
            }, 
            "Goodwill arising from acquisitions": {
                "value": 137, 
                "time": "6 months ended"
            }, 
            "Goodwill ending balance": {
                "value": 792, 
                "time": "6 months ended"
            }
        }, 
        "Diagnostics and Genomics Goodwill Roll Forward": {
            "Goodwill beginning balance": {
                "value": 1234, 
                "time": "6 months ended"
            }, 
            "Foreign currency translation impact": {
                "value": 44, 
                "time": "6 months ended"
            }, 
            "Goodwill arising from acquisitions": {
                "value": 0, 
                "time": "6 months ended"
            }, 
            "Goodwill ending balance": {
                "value": 1278, 
                "time": "6 months ended"
            }
        }, 
        "Agilent CrossLab Goodwill Roll Forward": {
            "Goodwill beginning balance": {
                "value": 482, 
                "time": "6 months ended"
            }, 
            "Foreign currency translation impact": {
                "value": 4, 
                "time": "6 months ended"
            }, 
            "Goodwill arising from acquisitions": {
                "value": 0, 
                "time": "6 months ended"
            }, 
            "Goodwill ending balance": {
                "value": 486, 
                "time": "6 months ended"
            }
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details) - USD ($) $ in Millions", 
        "Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": [
                {
                    "value": 1283, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1139, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated Amortization and Impairments": [
                {
                    "value": 793, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 694, 
                    "date": "oct 31 2015"
                }
            ], 
            "Net Book Value": [
                {
                    "value": 490, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 445, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Purchased Technology Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": [
                {
                    "value": 840, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 746, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated Amortization and Impairments": [
                {
                    "value": 535, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 476, 
                    "date": "oct 31 2015"
                }
            ], 
            "Net Book Value": [
                {
                    "value": 305, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 270, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Backlog Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": {
                "value": 1, 
                "date": "apr 30 2016"
            }, 
            "Accumulated Amortization and Impairments": {
                "value": 1, 
                "date": "apr 30 2016"
            }, 
            "Net Book Value": {
                "value": 0, 
                "date": "apr 30 2016"
            }
        }, 
        "Trademark/Tradenames Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": [
                {
                    "value": 154, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 141, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated Amortization and Impairments": [
                {
                    "value": 57, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 50, 
                    "date": "oct 31 2015"
                }
            ], 
            "Net Book Value": [
                {
                    "value": 97, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 91, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Customer Relationships Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": [
                {
                    "value": 266, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 230, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated Amortization and Impairments": [
                {
                    "value": 200, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 168, 
                    "date": "oct 31 2015"
                }
            ], 
            "Net Book Value": [
                {
                    "value": 66, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 62, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Total amortizable intangible assets Finite-Lived Intangible Assets, Net": {
            "Gross Carrying Amount": [
                {
                    "value": 1261, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1117, 
                    "date": "oct 31 2015"
                }
            ], 
            "Accumulated Amortization and Impairments": [
                {
                    "value": 793, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 694, 
                    "date": "oct 31 2015"
                }
            ], 
            "Net Book Value": [
                {
                    "value": 468, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 423, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "In-Process R&D Indefinite-Lived Intangible Assets (Excluding Goodwill)": {
            "In-Process R&D": [
                {
                    "value": 22, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 22, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details) - USD ($) $ in Millions", 
        "Finite-Lived Intangible Assets": {
            "Purchase price of Seahorse": {
                "value": 242, 
                "date": "nov 01 2015"
            }, 
            "Goodwill, Purchase Accounting Adjustments": {
                "value": 3, 
                "date": "apr 30 2016"
            }, 
            "Additions to goodwill": {
                "value": 137, 
                "date": "apr 30 2016"
            }, 
            "Addition to other intangible assets": {
                "value": 118, 
                "date": "apr 30 2016"
            }, 
            "Foreign exchange translation impact": {
                "value": 10, 
                "date": "apr 30 2016"
            }, 
            "Amortization of intangible assets during the period": [
                {
                    "value": 40, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 38, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 83, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 81, 
                    "date": "apr 30 2015"
                }
            ]
        }
    }, 
    {
        "title": "GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details) $ in Millions", 
        "Goodwill and Intangible Assets Disclosure [Abstract]": {
            "Remainder of 2016": {
                "value": 69, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "2017": {
                "value": 113, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "2018": {
                "value": 83, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "2019": {
                "value": 59, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "2020": {
                "value": 48, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "2021": {
                "value": 36, 
                "header_custom_remainder": "30 2016usd"
            }, 
            "Thereafter": {
                "value": 60, 
                "header_custom_remainder": "30 2016usd"
            }
        }
    }, 
    {
        "title": "FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions", 
        "Assets Short - term": {
            "Cash equivalents (money market funds)": [
                {
                    "value": 1454, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1411, 
                    "date": "oct 31 2015"
                }
            ], 
            "Derivative instruments (foreign exchange contracts)": [
                {
                    "value": 3, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Assets, Long-term": {
            "Trading securities": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total assets measured at fair value": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Liabilities, Short-term": {
            "Derivative instruments (foreign exchange and interest rate swap contracts)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Liabilities Long-term": {
            "Deferred compensation liability": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total liabilities measured at fair value": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Quoted Prices in Active Markets for Identical Assets (Level 1) Assets Short - term": {
            "Cash equivalents (money market funds)": [
                {
                    "value": 1454, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1411, 
                    "date": "oct 31 2015"
                }
            ], 
            "Derivative instruments (foreign exchange contracts)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Significant Other Observable Inputs (Level 2) Assets Short - term": {
            "Cash equivalents (money market funds)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Derivative instruments (foreign exchange contracts)": [
                {
                    "value": 3, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Significant Unobservable Inputs (Level 3) Assets Short - term": {
            "Cash equivalents (money market funds)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Derivative instruments (foreign exchange contracts)": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "FAIR VALUE MEASUREMENTS, Fair value measures and impairments (Details) - USD ($) $ in Millions", 
        "Long-Lived Assets": {
            "Impairment long-lived assets held and used": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Impairment of long-lived assets held for sale": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Investments": {
            "Impairment of Investments": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "DERIVATIVES (Details) $ in Millions", 
        "Derivative Instruments and Hedging Activities Disclosure": {
            "Debt instrument face amount": [
                {
                    "value": 600, 
                    "header_custom_remainder": "20 2014usd"
                }, 
                {
                    "value": 100, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 100, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ], 
            "Amount of extinguishment of debt": {
                "value": 500, 
                "header_custom_remainder": "20 2014usd"
            }
        }, 
        "Derivative Contracts": {
            "Foreign exchange forward contracts designated as cash flow hedge (in units) | contracts": [
                {
                    "value": 62, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 62, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ], 
            "Foreign exchange forward contracts not designated as hedges (in units) | contracts": [
                {
                    "value": 158, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 158, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ]
        }, 
        "Senior Notes 2020 Terminated Interest Rate Swaps": {
            "Number of Interest Rate Swap Contracts Designated as Fair Value Hedges Terminated (in units) | contracts": {
                "value": 5, 
                "header_custom_remainder": "09 2011usd contracts"
            }, 
            "Notional Amount of Terminated Interest Rate Swaps": {
                "value": 500, 
                "header_custom_remainder": "09 2011usd contracts"
            }, 
            "Amount to be amortized on terminated interest rates swaps": [
                {
                    "value": 17, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 17, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ]
        }, 
        "Senior Notes 2017 Terminated Interest Rate Swaps": {
            "Number of Interest Rate Swap Contracts Designated as Fair Value Hedges Terminated (in units) | contracts": {
                "value": 2, 
                "header_custom_remainder": "25 2008usd contracts"
            }, 
            "Notional Amount of Terminated Interest Rate Swaps": {
                "value": 400, 
                "header_custom_remainder": "25 2008usd contracts"
            }, 
            "Amount to be amortized on terminated interest rates swaps": [
                {
                    "value": 1, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 1, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ]
        }, 
        "Treasury Lock | Senior Notes 2022 | Cash Flow Hedging Derivative Instruments and Hedging Activities Disclosure": {
            "Notional amount of interest rate swap contract": {
                "value": 400, 
                "header_custom_remainder": "01 2012usd"
            }, 
            "Remaining gain to be amortized on derivative": [
                {
                    "value": 2, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 2, 
                    "header_custom_remainder": "30 2016usd contracts"
                }
            ]
        }, 
        "Interest Rate Swap [Member] | Cash Flow Hedging Derivative Instruments and Hedging Activities Disclosure": {
            "Notional amount of interest rate swap contract": {
                "value": 300, 
                "header_custom_remainder": "01 2016usd"
            }
        }, 
        "Designated as Hedging Instrument | Accumulated Other Comprehensive Income (Loss) | Interest Rate Swap [Member] | Cash Flow Hedging Derivative Instruments and Hedging Activities Disclosure": {
            "Gain (loss) recognized in accumulated other comprehensive income (loss)": [
                {
                    "value": -3, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 0, 
                    "header_custom_remainder": "30 2015usd"
                }, 
                {
                    "value": -3, 
                    "header_custom_remainder": "30 2016usd contracts"
                }, 
                {
                    "value": 0, 
                    "header_custom_remainder": "30 2015usd"
                }
            ]
        }
    }, 
    {
        "title": "DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details) $ in Millions", 
        "Sell | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 38, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 156, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Euro | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 56, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Euro | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 31, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | British Pound | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 4, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | British Pound | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 4, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | British Pound | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 31, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Canadian Dollar | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 2, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Canadian Dollar | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 3, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Canadian Dollar | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 27, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Australian Dollars | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 4, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Malaysian Ringgit | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 2, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Japanese Yen | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 1, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Japanese Yen | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 65, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Other | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 14, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Sell | Other | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 5, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 182, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Euro | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 116, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Australian Dollars | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 14, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Australian Dollars | Cash Flow Hedging | Forward Contracts USD Derivative": {
            "Total notional amount": {
                "value": 3, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Japanese Yen | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 21, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | United States of America, Dollars | Forward Contracts DKK | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 44, 
                "header_custom_remainder": "30 2016usd"
            }
        }, 
        "Buy | Other | Forward Contracts USD | Derivatives Not Designated as Hedging Instruments Derivative": {
            "Total notional amount": {
                "value": 39, 
                "header_custom_remainder": "30 2016usd"
            }
        }
    }, 
    {
        "title": "DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) - USD ($) $ in Millions", 
        "Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Asset": [
                {
                    "value": 3, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "oct 31 2015"
                }
            ], 
            "Total derivatives Liabilities": [
                {
                    "value": 13, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 5, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Other Current Assets Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Asset": [
                {
                    "value": 1, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Other Accrued Liabilities Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Liabilities": [
                {
                    "value": 11, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Current Assets Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Asset": [
                {
                    "value": 1, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Accrued Liabilities Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Liabilities": [
                {
                    "value": 8, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Interest Rate Swap [Member] | Other Current Assets Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Asset": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Interest Rate Swap [Member] | Other Accrued Liabilities Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Liabilities": [
                {
                    "value": 3, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Current Assets Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Asset": [
                {
                    "value": 2, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Accrued Liabilities Derivative Fair Value by Balance Sheet Location": {
            "Total derivatives Liabilities": [
                {
                    "value": 2, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) - USD ($) $ in Millions", 
        "Derivative": {
            "Gain (loss) recognized in accumulated other comprehensive income (loss)": [
                {
                    "value": -13, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Cash Flow Hedging | Cost of Sales Derivative": {
            "Cash Flow Hedge Net Gain to be Reclassified within Twelve Months": {
                "value": 7, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts | Accumulated Other Comprehensive Income (Loss) Derivative": {
            "Gain (loss) recognized in accumulated other comprehensive income (loss)": [
                {
                    "value": -10, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts | Cost of Sales Derivative": {
            "Gain reclassified from accumulated other comprehensive income (loss) into cost of sales": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap [Member] | Accumulated Other Comprehensive Income (Loss) Derivative": {
            "Gain (loss) recognized in accumulated other comprehensive income (loss)": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Derivatives Not Designated as Hedging Instruments | Other income (expense) Derivative": {
            "Gain (loss) recognized in other income (expense)": [
                {
                    "value": 5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -17, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details) - USD ($) $ in Millions", 
        "Curtailments and Settlements": {
            "Curtailments and settlements": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -16, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Pensions (U.S. Plans) Defined Benefit Plan, Net Periodic Benefit Cost": {
            "Service cost - benefits earned during the period": [
                {
                    "value": 6, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 12, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 12, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest cost on benefit obligation": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Expected return on plan assets": [
                {
                    "value": -6, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -7, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -12, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -14, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Amortization:": {
            "Actuarial losses": [
                {
                    "value": 2, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Prior service cost": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -6, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Total net plan costs": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Pensions (Non-U.S. Plans) Defined Benefit Plan, Net Periodic Benefit Cost": {
            "Service cost - benefits earned during the period": [
                {
                    "value": 5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 9, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest cost on benefit obligation": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 8, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 12, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Expected return on plan assets": [
                {
                    "value": -11, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -10, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -22, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -21, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "United States Post-retirement Benefit Plan Defined Benefit Plan, Net Periodic Benefit Cost": {
            "Service cost - benefits earned during the period": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest cost on benefit obligation": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Expected return on plan assets": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Textual) - USD ($) $ in Millions", 
        "Defined Benefit Plans Contributions": {
            "Curtailment gain": {
                "value": 15, 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }, 
            "Settlement gain": {
                "value": 1, 
                "time": "6 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Pensions (U.S. Plans) Defined Benefit Plans Contributions": {
            "Contributions to defined benefit plans": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 15, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 15, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Estimated future employer contributions in remainder of current fiscal year": {
                "value": 0, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }, 
        "Pensions (Non-U.S. Plans) Defined Benefit Plans Contributions": {
            "Contributions to defined benefit plans": [
                {
                    "value": 9, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 13, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Estimated future employer contributions in remainder of current fiscal year": {
                "value": 12, 
                "time": "3 months ended", 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "WARRANTIES AND CONTINGENCIES (Details) - USD ($) $ in Millions", 
        "Movement in Standard Product Warranty Accrual": {
            "Beginning balance at beginning of period": [
                {
                    "value": 31, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 30, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Accruals for warranties including change in estimate": [
                {
                    "value": 33, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 22, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Settlements made during the period": [
                {
                    "value": -27, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -24, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending balance at end of period": [
                {
                    "value": 37, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 28, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }, 
        "Standard Product Warranty Disclosure": {
            "Accruals for warranties due within one year": [
                {
                    "value": 36, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 26, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Accruals for warranties due after one year": [
                {
                    "value": 1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending balance at end of period": [
                {
                    "value": 37, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 28, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "SHORT-TERM DEBT Credit Facility (Details) - USD ($) $ in Millions", 
        "Line of Credit Facility": {
            "Credit facility limit increase": {
                "value": 300, 
                "date": "jun 09 2015"
            }, 
            "Amount outstanding on credit facility": {
                "value": 235, 
                "date": "apr 30 2016"
            }
        }, 
        "Line of Credit Line of Credit Facility": {
            "Initiation date of credit facility": {
                "value": "Sep. 15,\n\t\t2014", 
                "date": "sep 15 2014"
            }, 
            "Expiration date of credit facility": {
                "value": "Sep. 15,\n\t\t2019", 
                "date": "sep 15 2014"
            }, 
            "Credit faciity terms (in years)": {
                "value": "five", 
                "date": "sep 15 2014"
            }, 
            "Initial maximum borrowing capacity of credit facility": {
                "value": 400, 
                "date": "sep 15 2014"
            }, 
            "New maximum borrowing capacity of credit facility": {
                "value": 700, 
                "date": "apr 30 2016"
            }
        }
    }, 
    {
        "title": "LONG-TERM DEBT (Details) - USD ($) $ in Millions", 
        "Debt Instrument": {
            "Long-term debt": [
                {
                    "value": 1596, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1596, 
                    "date": "oct 31 2015"
                }
            ], 
            "Interest Rate Swap": [
                {
                    "value": 18, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 21, 
                    "date": "oct 31 2015"
                }
            ], 
            "Carrying Value of Senior Notes": [
                {
                    "value": 1614, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1617, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Senior Notes 2017 Debt Instrument": {
            "Long-term debt": [
                {
                    "value": 100, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 100, 
                    "date": "oct 31 2015"
                }
            ], 
            "Interest Rate Swap": [
                {
                    "value": 1, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "oct 31 2015"
                }
            ], 
            "Carrying Value of Senior Notes": [
                {
                    "value": 101, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 102, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Senior Notes 2020 Debt Instrument": {
            "Long-term debt": [
                {
                    "value": 499, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 499, 
                    "date": "oct 31 2015"
                }
            ], 
            "Interest Rate Swap": [
                {
                    "value": 17, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 19, 
                    "date": "oct 31 2015"
                }
            ], 
            "Carrying Value of Senior Notes": [
                {
                    "value": 516, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 518, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Senior Notes 2022 Debt Instrument": {
            "Long-term debt": [
                {
                    "value": 399, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 399, 
                    "date": "oct 31 2015"
                }
            ], 
            "Interest Rate Swap": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Carrying Value of Senior Notes": [
                {
                    "value": 399, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 399, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Senior Notes 2023 Debt Instrument": {
            "Long-term debt": [
                {
                    "value": 598, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 598, 
                    "date": "oct 31 2015"
                }
            ], 
            "Interest Rate Swap": [
                {
                    "value": 0, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "oct 31 2015"
                }
            ], 
            "Carrying Value of Senior Notes": [
                {
                    "value": 598, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 598, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "LONG-TERM DEBT LONG-TERM DEBT - Other Debt (Details) - USD ($) $ in Millions", 
        "Other Long-term Debt": {
            "Mortgage Loans on Real Estate": [
                {
                    "value": 40, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 38, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }, 
    {
        "title": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details) - USD ($) shares in Millions, $ in Millions", 
        "Share repurchase program": {
            "Cost to repurchases shares of common stock under share repurchase program": [
                {
                    "value": 294, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 168, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "2014 Share Repurchase Program Share repurchase program": {
            "Share repurchase program authorized amount": {
                "value": 1000, 
                "date": "nov 22 2013"
            }, 
            "Maintain weighted average diluted shares count (in shares)": {
                "value": 335, 
                "date": "nov 22 2013"
            }, 
            "Cost to repurchases shares of common stock under share repurchase program": [
                {
                    "value": 168, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 98, 
                    "date": "apr 30 2016"
                }
            ], 
            "Number of shares repurchased (in shares)": [
                {
                    "value": 4, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 2.4, 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "2015 Repurchase Program Share repurchase program": {
            "Share repurchase program authorized amount": {
                "value": 1140, 
                "date": "may 28 2015"
            }, 
            "Cost to repurchases shares of common stock under share repurchase program": [
                {
                    "value": 94, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 196, 
                    "date": "apr 30 2016"
                }
            ], 
            "Number of shares repurchased (in shares)": [
                {
                    "value": 2.6, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 5.1, 
                    "date": "apr 30 2016"
                }
            ], 
            "Remaining authorized repurchase amount under share repurchase program": [
                {
                    "value": 944, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 944, 
                    "date": "apr 30 2016"
                }
            ]
        }
    }, 
    {
        "title": "STOCKHOLDER\"S EQUITY - Dividends (Details) - USD ($) $ / shares in Units, $ in Millions", 
        "Dividends Paid": {
            "Aggregate amount of cash dividends paid": [
                {
                    "value": 37, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 33, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 75, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 67, 
                    "date": "apr 30 2015"
                }
            ], 
            "Cash dividends paid per common share": [
                {
                    "value": 0.115, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.1, 
                    "date": "apr 30 2015"
                }, 
                {
                    "value": 0.23, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0.2, 
                    "date": "apr 30 2015"
                }
            ]
        }, 
        "Dividends Declared Subsequent Events [Abstract]": {
            "Declaration date": {
                "value": "May 18,\n\t\t2016", 
                "date": "may 18 2016"
            }, 
            "Cash dividends declared per common share": {
                "value": 0.115, 
                "date": "may 18 2016"
            }, 
            "Aggregate amount of dividends declared": {
                "value": 37, 
                "date": "may 18 2016"
            }, 
            "Payment date": {
                "value": "Jul. 27,\n\t\t2016", 
                "date": "may 18 2016"
            }, 
            "Date of record": {
                "value": "Jul. 5,\n\t\t2016", 
                "date": "may 18 2016"
            }
        }
    }, 
    {
        "title": "STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions", 
        "STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions": {
            "Beginning Balance": [
                {
                    "value": -438, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -391, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss), before reclassifications": [
                {
                    "value": 140, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 99, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Amounts reclassified out of accumulated other comprehensive income (loss)": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Tax (expense) benefit": [
                {
                    "value": -5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss)": [
                {
                    "value": 139, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 92, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -268, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending Balance": [
                {
                    "value": -299, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -299, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Foreign currency translation": {
            "Beginning balance": [
                {
                    "value": -245, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -189, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss) before reclassifications": [
                {
                    "value": 153, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 96, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Amounts reclassified out of accumulated other comprehensive income (loss)": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Tax (expense) benefit": [
                {
                    "value": -8, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax": [
                {
                    "value": 145, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 89, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -271, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": -100, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -100, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Prior service credits": {
            "Beginning balance": [
                {
                    "value": 153, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 161, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss) before reclassifications": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Amounts reclassified out of accumulated other comprehensive income (loss)": [
                {
                    "value": -4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -23, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Tax (expense) benefit": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss)": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -11, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": 150, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 150, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss), Net Actuarial Gain (Loss), before Tax": {
            "Beginning balance": [
                {
                    "value": -350, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -365, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss) before reclassifications": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Amounts reclassified out of accumulated other comprehensive income (loss)": [
                {
                    "value": 9, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 8, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 22, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 17, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Tax (expense) benefit": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss)": [
                {
                    "value": 6, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 6, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 21, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 10, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": -344, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -344, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }, 
        "Unrealized gains (losses) on derivatives": {
            "Beginning balance": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss) before reclassifications": [
                {
                    "value": -13, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Amounts reclassified out of accumulated other comprehensive income (loss)": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Tax (expense) benefit": [
                {
                    "value": 5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Other comprehensive income (loss)": [
                {
                    "value": -9, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -7, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ], 
            "Ending balance": [
                {
                    "value": -5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }
            ]
        }
    }, 
    {
        "title": "STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details) - USD ($) $ in Millions", 
        "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives": {
            "Unrealized gains and (losses) on derivatives reclassified to cost of products": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Unrealized gains and (losses) on derivatives reclassified to cost of products, before tax": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Reclassification of (gains) and losses into earnings related to derivative instruments, tax": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Unrealized gains and (losses) on derivatives reclassified to cost of products, net of tax": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 5, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Actuarial net loss": [
                {
                    "value": -9, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -8, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -22, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -17, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Prior service benefit": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 23, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Actuarial net loss and prior service benefit reclassified, before tax": [
                {
                    "value": -5, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -9, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Tax on actuarial net loss and prior service benefit reclassified": [
                {
                    "value": 2, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -2, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Actuarial net loss and prior service benefit reclassified, net of tax": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -1, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -8, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax": [
                {
                    "value": -3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "SEGMENT INFORMATION - Profitability (Details) $ in Millions", 
        "Segment Reporting [Abstract]": {
            "Number of operating segments": {
                "value": 3, 
                "time": "3 months ended"
            }
        }, 
        "Select Income Statement Components": {
            "Total net revenue": [
                {
                    "value": 1019, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 963
                }, 
                {
                    "value": 2047, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 1989
                }
            ], 
            "Income from operations": [
                {
                    "value": 131, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 107
                }, 
                {
                    "value": 286, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 222
                }
            ]
        }, 
        "Life Sciences and Applied Markets Select Income Statement Components": {
            "Total net revenue": [
                {
                    "value": 495, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 473
                }, 
                {
                    "value": 1021, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 1020
                }
            ], 
            "Income from operations": [
                {
                    "value": 94, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 75
                }, 
                {
                    "value": 208, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 182
                }
            ]
        }, 
        "Diagnostics and Genomics Select Income Statement Components": {
            "Total net revenue": [
                {
                    "value": 178, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 169
                }, 
                {
                    "value": 336, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 317
                }
            ], 
            "Income from operations": [
                {
                    "value": 27, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 25
                }, 
                {
                    "value": 42, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 26
                }
            ]
        }, 
        "Agilent CrossLab Select Income Statement Components": {
            "Total net revenue": [
                {
                    "value": 346, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 321
                }, 
                {
                    "value": 690, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 652
                }
            ], 
            "Income from operations": [
                {
                    "value": 74, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 69
                }, 
                {
                    "value": 150, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 137
                }
            ]
        }, 
        "Segment Total Select Income Statement Components": {
            "Total net revenue": [
                {
                    "value": 1019, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 963
                }, 
                {
                    "value": 2047, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 1989
                }
            ], 
            "Income from operations": [
                {
                    "value": 195, 
                    "time": "3 months ended"
                }, 
                {
                    "value": 169
                }, 
                {
                    "value": 400, 
                    "time": "6 months ended"
                }, 
                {
                    "value": 345
                }
            ]
        }
    }, 
    {
        "title": "SEGMENT INFORMATION - Reconciliation of Reportable Results (Details) - USD ($) $ in Millions", 
        "Reconciliation of Operating Profit (Loss) from Segments to Consolidated": {
            "Total reportable segments income from operations": [
                {
                    "value": 195, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 169, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 400, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 345, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Acceleration of share-based compensation related to workforce reduction": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 0, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Transformational initiatives": [
                {
                    "value": -10, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -17, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -21, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -29, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Amortization of intangibles": [
                {
                    "value": -40, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -38, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -83, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -81, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Acquisition and integration costs": [
                {
                    "value": -12, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -1, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -17, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Business exit and divestiture costs (primarily our NMR business)": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -8, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -6, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -11, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Pension curtailment gain": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 16, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 0, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other": [
                {
                    "value": -1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 3, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -3, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest income": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 5, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Interest expense": [
                {
                    "value": -18, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -17, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": -36, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": -33, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Other income (expense), net": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 4, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 16, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ], 
            "Income from continuing operations before taxes": [
                {
                    "value": 117, 
                    "time": "3 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 96, 
                    "date": "apr 30 2015", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 259, 
                    "time": "6 months ended", 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 209, 
                    "date": "apr 30 2015", 
                    "time": "6 months ended"
                }
            ]
        }
    }, 
    {
        "title": "SEGMENT INFORMATION - Segment Assets (Details) - USD ($) $ in Millions", 
        "Segment Reporting Information": {
            "Assets": [
                {
                    "value": 7640, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 7479, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Life Sciences and Applied Markets Segment Reporting Information": {
            "Assets": [
                {
                    "value": 1699, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1539, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Diagnostics and Genomics Segment Reporting Information": {
            "Assets": [
                {
                    "value": 2052, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 2027, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Agilent CrossLab Segment Reporting Information": {
            "Assets": [
                {
                    "value": 1062, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 1008, 
                    "date": "oct 31 2015"
                }
            ]
        }, 
        "Segment Total Segment Reporting Information": {
            "Assets": [
                {
                    "value": 4813, 
                    "date": "apr 30 2016"
                }, 
                {
                    "value": 4574, 
                    "date": "oct 31 2015"
                }
            ]
        }
    }
]